Diagnoses used for exclusion with ILD

ILD_FOR_EXCL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_PULMEOS J10_HYPERSPNEUMONI J10_EXTERLUNG D3_SARCOIDOSIS	11752
6. Filter based on genotype QC (FinnGen only)	11752

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ILD_FOR_EXCL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_PULMEOS\|J10_HYPERSPNEUMONI\|J10_EXTERLUNG\|D3_SARCOIDOSIS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diagnoses used for exclusion with ILD based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11752	5172	6580
Unadjusted period prevalence (%)	2.40	1.76	2.90
Median age at first event (years)	56.81	51.92	60.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10573: Matched controls
105722

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

3447.3

323.0

344

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

323.0

457

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

323.0

5718

32634

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

323.0

426

132

Kela drug reimbursment

Sarcoidosis

+∞

323.0

897

13597

ICD-8 Finland

Sarcoidosis, Suspecta

+∞

323.0

524

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.9

323.0

2296

5693

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

7.9

323.0

1420

2033

TGC00

NOMESCO Finland

Bronchial lavation

11.5

323.0

951

900

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

323.0

3589

17862

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

323.0

833

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

323.0

1122

D86.0

ICD-10 Finland

Sarcoidosis of lung

7395.0

323.0

1871

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2717.5

323.0

2671

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

11478.7

323.0

1047

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

377.8

323.0

678

H02AB06

ATC

prednisolone; systemic

2.7

323.0

6090

35234

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

323.0

1270

D86.3

ICD-10 Finland

Sarcoidosis of skin

3341.0

323.0

334

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

323.0

316

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.6

323.0

1995

4181

XG410

NOMESCO Finland

Flow-volume spirometry

5.5

285.1

909

1781

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.9

278.2

733

1122

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

256.1

2210

9705

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

+∞

244.7

234

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

761.1

228.0

224

D86

ICD-10 Finland

Sarcoidosis

750.6

224.9

221

GEA00

NOMESCO Finland

Mediastinoscopy

36.5

221.7

288

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

7.5

218.2

540

750

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.8

207.4

973

2772

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

204.7

1313

4738

J69.8

ICD-10 Finland

Pneumonitis due to other solids and liquids

+∞

198.5

190

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

15.5

185.3

313

208

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

919.2

184.9

181

J67.0

ICD-10 Finland

Farmer lung

1885.3

181.6

176

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

5.5

179.4

560

1057

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.2

173.6

576

1166

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.5

171.5

868

2616

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

170.8

2051

10392

R03AC02

ATC

salbutamol; inhalant

1.8

169.4

5292

38182

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

166.9

2043

10428

R06.0

ICD-10 Finland

Dyspnoea

2.0

161.0

2802

16491

A02BC02

ATC

pantoprazole; systemic

1.7

158.1

6661

52196

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

156.8

3474

22242

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

388.0

153.6

154

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

144.9

678

1909

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

139.6

1258

5484

AA1AD

NOMESCO Finland

CT of head and brain

1.8

131.6

2666

16351

C03CA01

ATC

furosemide; systemic

1.7

129.6

3468

23233

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.1

129.3

787

2701

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

125.3

981

3944

R50.9

ICD-10 Finland

Fever, unspecified

2.1

123.8

1582

8115

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

36.7

122.9

159

WX892

NOMESCO Finland

Monitored bed care

2.6

122.6

987

4029

J01MA12

ATC

levofloxacin; systemic

1.9

121.0

2147

12515

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

18.4

120.7

190

105

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.3

119.6

387

758

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

115.5

858

3338

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.7

115.0

547

1556

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

114.8

3012

19889

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

114.4

2312

14053

L04AX01

ATC

azathioprine; systemic

3.4

114.1

596

1827

M05BA04

ATC

alendronic acid; oral

2.4

111.9

1013

4399

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.2

110.8

448

1104

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

11.2

110.8

215

195

4950A

ICD-9 Finland

Extrinsic allergic alveolitis, Farmers' lung

+∞

110.6

106

M14.8*D86.8

ICD-10 Finland

Arthropathy in sarcoidosis

+∞

108.5

104

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

100.9

2071

12581

J01MA14

ATC

moxifloxacin; systemic

2.3

97.6

1034

4838

R03BA02

ATC

budesonide; inhalant

1.9

96.0

1769

10345

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

+∞

93.9

ZXD05

NOMESCO Finland

Urgent procedure

1.6

93.1

3107

21659

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.6

92.8

341

765

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

92.3

1278

6708

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

91.0

2140

13506

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

90.7

1386

7561

4959X

ICD-9 Finland

Extrinsic allergic alveolitis, Unspecified allergic alveolitis and pneumonitis

+∞

87.6

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

86.5

848

3811

R05

ICD-10 Finland

Cough

1.8

86.2

1836

11214

WX730

NOMESCO Finland

Conventional respirator

4.9

86.0

292

603

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

33.6

85.9

113

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

+∞

83.4

C07AB07

ATC

bisoprolol; oral

1.5

82.4

4801

37836

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

81.5

2114

13670

51610

ICD-8 Finland

Other pneumoconiosis and related diseases, Due to inhalation of other dust

+∞

81.3

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

+∞

81.3

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

6.4

80.8

221

352

5070A

ICD-9 Finland

Pneumonitis due to solids and liquids, Due to inhalation of food or vomitus

+∞

80.3

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

15.9

79.7

132

N05AH04

ATC

quetiapine; oral

1.8

79.6

1509

8852

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

8.2

79.4

183

227

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

79.4

1745

10735

R03BB04

ATC

tiotropium bromide; inhalant

2.0

78.4

1178

6358

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

76.9

1459

8550

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

76.0

1107

5902

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

75.5

4594

36283

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

73.0

1567

9542

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

8.0

71.7

167

211

H02AB07

ATC

prednisone; oral

1.8

70.3

1460

8788

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

11.9

70.0

131

111

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.1

70.0

232

467

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

69.8

894

4517

R03BA01

ATC

beclometasone; inhalant

1.8

68.0

1398

8382

N03AG01

ATC

valproic acid; systemic, rectal

2.4

67.5

622

2701

TGD00

NOMESCO Finland

Needle biopsy of lung

10.0

66.2

135

136

JN4BD

NOMESCO Finland

Extensive body CT

1.9

66.1

1133

6388

JDB10

NOMESCO Finland

Percutaneous gastrostomy

5.0

65.8

219

443

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

+∞

65.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

65.1

2498

17705

J66.8

ICD-10 Finland

Airway disease due to other specific organic dusts

+∞

64.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

64.3

478

1846

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

63.9

1719

11135

H02AB04

ATC

methylprednisolone; systemic

1.7

63.5

1427

8778

R03BA08

ATC

ciclesonide; inhalant

2.1

62.5

767

3803

R13

ICD-10 Finland

Dysphagia

2.2

61.2

675

3194

J01FA06

ATC

roxithromycin; oral

1.4

61.1

3735

29122

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

61.0

542

2309

1240

FHL

Bronchoscopy

4.7

60.8

213

456

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

59.9

400

1448

WX872

NOMESCO Finland

Intensive care

2.4

59.5

556

2430

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

59.2

1543

9887

R53

ICD-10 Finland

Malaise and fatigue

1.6

59.0

1918

13021

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

59.0

1759

11682

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

58.6

1553

9992

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

58.6

573

2559

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

57.9

625

2925

Z2446

NOMESCO Finland

Social worker

2.2

57.6

640

3034

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

57.6

386

1399

ZX120

NOMESCO Finland

Intravenous

1.9

57.2

934

5167

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.6

57.1

173

315

J68.0

ICD-10 Finland

Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours

561.0

56.7

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

+∞

56.3

L52

ICD-10 Finland

Erythema nodosum

8.5

56.0

125

148

A06AD11

ATC

lactulose; oral

1.6

55.8

1562

10187

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.2

55.6

179

350

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

55.6

858

4647

TAB00

NOMESCO Finland

Lumbar puncture

2.5

55.5

445

1793

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

+∞

55.2

A02BC01

ATC

omeprazole; systemic

1.5

54.8

2648

19600

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

53.7

741

3845

J01DB01

ATC

cefalexin; oral

1.4

53.6

7706

69246

ZXE00

NOMESCO Finland

One hour or less

1.4

53.6

3596

28334

J68.3

ICD-10 Finland

Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours

+∞

53.2

N05CF01

ATC

zopiclone; oral

1.4

52.2

3092

23775

Z3231

NOMESCO Finland

Registered nurse

1.5

51.9

2552

18917

H20.1

ICD-10 Finland

Chronic iridocyclitis

5.1

51.9

169

335

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

51.9

1462

9536

TFJ02

NOMESCO Finland

Muscle biopsy of heart

18.1

51.8

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

51.7

1127

6841

J96.1

ICD-10 Finland

Chronic respiratory failure

3.1

51.5

298

982

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

51.2

856

4768

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

+∞

51.1

R03BA05

ATC

fluticasone; inhalant

1.6

51.0

1585

10599

N06AX11

ATC

mirtazapine; oral

1.4

50.8

2774

20982

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.5

50.0

404

1635

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

49.3

358

1364

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.2

48.9

193

466

L04AA06

ATC

mycophenolic acid; systemic

3.8

48.8

218

589

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

48.5

923

5363

J69

ICD-10 Finland

Pneumonitis due to solids and liquids

246.1

48.0

N02AA05

ATC

oxycodone; systemic

1.6

48.0

1417

9335

J01DA01

ATC

[U] cefalexin; systemic

1.3

47.7

5877

50866

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.1

47.7

280

930

WZC30

NOMESCO Finland

Teaching

1.7

47.7

1166

7306

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

3.6

47.7

223

626

J01AA02

ATC

doxycycline; systemic

1.4

47.5

7422

66730

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

47.1

2991

23192

N05BA01

ATC

diazepam; systemic, rectal

1.6

46.9

1243

7959

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

46.8

1246

7991

N02BE01

ATC

paracetamol; systemic, rectal

1.4

46.5

8226

75385

J63.3

ICD-10 Finland

Graphite fibrosis (of lung)

+∞

45.9

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

9.2

45.7

106

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.1

45.5

267

886

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

45.3

941

5618

N06AB04

ATC

citalopram; systemic

1.5

45.3

1890

13487

J96.0

ICD-10 Finland

Acute respiratory failure

3.9

45.1

194

508

A02BC05

ATC

esomeprazole; systemic

1.4

45.0

3601

29003

J62.0

ICD-10 Finland

Pneumoconiosis due to talc dust

+∞

44.8

JN4AD

NOMESCO Finland

Body CT examination

1.9

44.7

737

4077

N03AX16

ATC

pregabalin; oral

1.5

43.9

2054

14993

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

43.9

622

3256

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

43.5

3279

26108

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

43.5

408

1786

J01FF01

ATC

clindamycin; systemic

1.4

43.3

2387

17981

R4130

NOMESCO Finland

Speech therapy

3.1

43.3

243

785

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

5.4

42.9

132

246

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

42.9

1619

11288

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

42.4

485

2327

N05BA04

ATC

oxazepam; oral

1.4

42.2

2158

16013

N02AX02

ATC

tramadol; systemic, rectal

1.3

42.1

3912

32167

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

42.1

696

3852

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

41.6

1093

6967

A02BC03

ATC

lansoprazole; oral

1.4

41.6

2652

20485

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

41.3

2729

21209

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

41.3

670

3686

P01BA02

ATC

hydroxychloroquine; oral

1.8

41.1

706

3961

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

40.7

798

4674

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

40.6

1546

10786

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

40.5

544

2789

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.5

39.9

330

1350

H02AB09

ATC

hydrocortisone; systemic

3.0

39.7

237

799

N16.2

ICD-10 Finland

Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism

+∞

39.6

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

39.6

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

+∞

39.6

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

39.3

650

3595

N05AX08

ATC

risperidone; systemic

1.8

39.3

766

4475

SPAT1262

SPAT

Handing over of treatment supplies

1.5

39.1

1665

11885

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.1

39.0

224

735

R03AC03

ATC

terbutaline; inhalant

1.6

38.8

1177

7781

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

38.7

2748

21567

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

38.5

641

3557

Z3226

NOMESCO Finland

Physiotherapist

1.5

38.2

1627

11612

J68.9

ICD-10 Finland

Unspecified respiratory condition due to chemicals, gases, fumes and vapours

378.8

38.0

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

378.8

38.0

N03AX09

ATC

lamotrigine; oral

2.3

37.9

372

1663

N03AX14

ATC

levetiracetam; systemic

2.7

37.9

268

1006

SPAT1263

SPAT

Sampling

1.3

37.8

3670

30234

WX882

NOMESCO Finland

High dependency care

2.6

37.7

291

1150

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

37.7

662

3740

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

+∞

37.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

37.5

1774

12930

TJD20

NOMESCO Finland

Change of gastrostomy tube

7.7

37.4

115

N06AX16

ATC

venlafaxine; oral

1.6

37.3

1047

6782

R06.2

ICD-10 Finland

Wheezing

2.2

37.1

393

1820

SPAT1254

SPAT

Administration of medicine

1.5

37.1

1334

9171

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

37.0

688

3958

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

36.6

960

6109

N05AA02

ATC

levomepromazine; systemic

2.2

36.5

408

1936

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

36.4

1170

7836

SPAT1255

SPAT

Intravenous administration of medicine

1.8

36.4

614

3422

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

36.3

503

2608

J47

ICD-10 Finland

Bronchiectasis

3.1

36.2

210

695

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

36.1

969

6205

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

36.1

705

4121

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

35.9

524

2769

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.6

35.8

144

G47.3

ICD-10 Finland

Sleep apnoea

1.4

35.7

1815

13394

L28

ICPC

Limited function/disability (L)

1.5

35.7

1427

10036

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

35.6

1243

8483

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

35.6

1666

12104

J01CA04

ATC

amoxicillin; systemic

1.3

35.1

7309

66648

AP4

Myocardial biopsy

15.3

35.1

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.7

34.7

102

181

A46

ICD-10 Finland

Erysipelas

1.5

34.7

1265

8715

M14.8

ICD-10 Finland

Arthropathies in other specified diseases classified elsewhere

123.7

34.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

34.6

1525

10939

A28

ICPC

Limited function/disability NOS

1.5

34.2

1415

10014

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

34.2

2180

16738

H30.2

ICD-10 Finland

Posterior cyclitis

10.4

33.9

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

33.9

249

957

R11

ICD-10 Finland

Nausea and vomiting

1.7

33.9

673

3953

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

11.1

33.5

B01AB05

ATC

enoxaparin; parenteral

1.3

33.5

2630

20886

J45.8

ICD-10 Finland

Mixed asthma

2.4

33.4

295

1253

GBB00

NOMESCO Finland

Tracheostomy

3.7

33.3

152

420

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

33.3

487

2577

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

33.1

3489

28926

R04.2

ICD-10 Finland

Haemoptysis

2.2

33.1

352

1633

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

33.1

210

739

N03AE01

ATC

clonazepam; systemic

1.9

33.0

513

2776

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

32.9

3175

25991

R51.80

ICD-10 Finland

Headache

1.5

32.8

1064

7134

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

32.7

365

1732

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

32.7

406

2013

B01AA03

ATC

warfarin; systemic

1.4

32.5

2046

15661

R03DC03

ATC

montelukast; oral

1.5

32.4

1225

8496

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

32.1

1199

8292

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.6

31.9

148

415

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

31.9

705

4272

UJF32

NOMESCO Finland

Coloscopy

1.4

31.7

2244

17502

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

31.7

427

2193

R81

ICPC

Pneumonia

2.3

31.6

308

1375

N05CD07

ATC

temazepam; oral

1.5

31.5

1212

8441

E0000UV

ATC

1.3

31.4

3231

26651

Z2221

NOMESCO Finland

Medical doctor

1.3

31.3

2350

18496

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

6.9

31.1

116

N05AH03

ATC

olanzapine; systemic

1.9

31.0

469

2512

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

31.0

615

3609

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.4

30.9

269

1134

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

30.2

948

6298

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

30.1

393

1990

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

30.1

734

4571

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.4

30.1

111

254

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

30.0

206

762

1440

FHL

Mediastinoscopy

17.5

30.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

29.9

1988

15323

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.2

29.8

102

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

29.7

1327

9518

XG405

NOMESCO Finland

Education on PEF monitoring

3.2

29.7

163

521

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

29.5

252

1053

J01MA02

ATC

ciprofloxacin; systemic

1.3

29.5

3528

29627

R4110

NOMESCO Finland

Physiotherapy

1.3

29.4

2233

17577

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.5

29.4

WX704

NOMESCO Finland

Intubation

1.7

29.3

596

3525

R03AC12

ATC

salmeterol; inhalant

1.9

29.3

448

2409

WX722

NOMESCO Finland

PEEP

1.9

29.2

444

2383

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

+∞

29.2

I47.2

ICD-10 Finland

Ventricular tachycardia

2.5

29.2

233

940

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

28.9

525

2997

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.4

28.8

145

435

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

28.7

535

3077

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

28.5

592

3519

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

28.4

879

5817

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

28.4

264

1152

R55

ICD-10 Finland

Syncope and collapse

1.5

28.3

972

6589

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.6

28.1

131

370

H26.3

ICD-10 Finland

Drug-induced cataract

5.4

28.0

158

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

28.0

2311

18401

ZY010

NOMESCO Finland

Hospital outpatient

2.0

28.0

350

1743

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

28.0

132

377

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

7.1

27.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

27.9

2228

17656

N03AX12

ATC

gabapentin; oral

1.4

27.8

1251

8981

N06AX21

ATC

duloxetine; oral

1.6

27.7

806

5253

F1246

NOMESCO Finland

10.4

27.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

27.6

3205

26753

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

27.5

842

5558

C03DA01

ATC

spironolactone; oral

1.5

27.4

986

6750

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

27.4

632

3875

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

27.4

405

2153

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

27.2

379

1967

R03AC13

ATC

formoterol; inhalant

1.8

27.2

449

2480

XF404

NOMESCO Finland

Ambulatory ECG

1.6

27.2

806

5278

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

27.0

431

2354

N06AA09

ATC

amitriptyline; systemic

1.6

26.9

837

5545

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

26.9

1194

8542

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

26.5

772

5033

R03BB01

ATC

ipratropium bromide; inhalant

1.8

26.5

439

2430

S97

ICPC

Chronic ulcer skin

1.8

26.3

487

2794

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

26.1

334

1677

R03DA04

ATC

theophylline; systemic, rectal

1.7

26.1

564

3391

51620

ICD-8 Finland

Other pneumoconiosis and related diseases, Due to inhalation of fumes

+∞

26.0

D21

ICPC

Swallowing problem

3.1

25.9

145

471

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

25.9

319

1580

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

25.8

906

6170

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

25.8

466

2656

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

25.6

672

4264

J46

ICD-10 Finland

Status asthmaticus

2.3

25.6

240

1053

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

25.5

2539

20718

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

25.5

508

2984

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

25.4

2364

19111

A07AA02

ATC

nystatin; oral

1.7

25.3

531

3167

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

25.1

213

888

N03AF02

ATC

oxcarbazepine; oral

2.2

25.1

269

1258

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

25.1

852

5759

M05BA07

ATC

risedronic acid; oral

2.1

25.0

285

1368

R02

ICPC

Shortness of breath/dyspnoea

1.5

25.0

966

6714

J01FA09

ATC

clarithromycin; systemic

1.3

25.0

2461

20041

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

24.7

513

3048

K90

ICPC

Stroke/cerebrovascular accident

2.2

24.6

263

1227

A10AE04

ATC

insulin glargine; parenteral

1.5

24.6

820

5518

N03AF01

ATC

carbamazepine; oral, rectal

1.8

24.5

462

2664

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

24.5

451

2582

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

24.5

209

875

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

24.4

1431

10763

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

24.4

448

2564

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.7

24.4

109

299

N06AB10

ATC

escitalopram; oral

1.4

24.3

1408

10568

SPAT1229

SPAT

Assessment of need for aid

1.6

24.2

700

4555

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.7

24.0

175

K77.8*D86.8

ICD-10 Finland

Hepatic granulomas in sarcoidosis

+∞

24.0

J63.8

ICD-10 Finland

Pneumoconiosis due to other specified inorganic dusts

+∞

24.0

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.1

23.9

286

1398

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.0

23.9

138

458

WX110

NOMESCO Finland

Local anesthesy

1.2

23.9

5777

52229

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

23.9

325

1675

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

23.8

790

5312

SPAT1301

SPAT

No procedures

1.3

23.8

2670

22100

Z2445

NOMESCO Finland

Psychologist

2.1

23.7

280

1364

H03AA01

ATC

levothyroxine sodium; systemic

1.3

23.6

1774

13884

69520

ICD-8 Finland

Erythematous condition, Erythema nodosum

10.8

23.5

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

23.4

528

3215

G72.8

ICD-10 Finland

Other specified myopathies

2.7

23.3

164

618

XQ800

NOMESCO Finland

Prick test

1.7

23.2

489

2921

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

23.1

550

3400

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

23.1

134

447

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

23.1

1487

11355

P01AB01

ATC

metronidazole; oral, rectal

1.3

23.0

3152

26705

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

23.0

423

2427

N05AX12

ATC

aripiprazole; systemic

2.2

22.9

245

1142

E83.50

ICD-10 Finland

Hypercalcemia

3.1

22.9

128

417

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

22.8

267

1298

R40.2

ICD-10 Finland

Coma, unspecified

3.4

22.7

112

333

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

22.6

863

5980

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.3

22.6

114

345

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

22.6

386

2160

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

22.3

636

4126

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

22.2

2160

17518

S06.0

ICD-10 Finland

Concussion

1.5

22.1

804

5509

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

22.0

178

726

A04

ICPC

Weakness/tiredness general

1.4

22.0

1005

7219

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.6

21.9

160

616

R60.0

ICD-10 Finland

Localized oedema

1.5

21.9

896

6299

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

21.9

542

3389

J60

ICD-10 Finland

Coalworker pneumoconiosis

+∞

21.9

Z57.2

ICD-10 Finland

Occupational exposure to dust

5.7

21.7

112

WX002

NOMESCO Finland

Sedation and analgesia

1.3

21.7

1596

12433

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

21.7

472

2848

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

21.7

133

462

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

21.6

353

1947

D07AC01

ATC

betamethasone; topical

1.3

21.6

2822

23743

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

21.5

360

2001

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

21.5

290

1492

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.9

21.4

135

476

L04AD01

ATC

ciclosporin; systemic

2.6

21.3

161

634

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.6

21.3

163

645

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

21.2

1317

9986

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.5

21.1

172

704

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

21.1

3486

30108

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

21.0

574

3678

C09AA05

ATC

ramipril; oral

1.3

21.0

2214

18127

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

21.0

183

776

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

20.9

200

889

D72.1

ICD-10 Finland

Eosinophilia

5.9

20.7

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.4

20.7

103

309

F2680

NOMESCO Finland

7.6

20.7

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.2

20.7

108

336

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

20.7

421

2490

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.6

20.6

258

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

20.5

180

765

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

20.4

195

867

127

Kela drug reimbursment

Transplant complication

2.7

20.4

138

508

A10AE05

ATC

insulin detemir; parenteral

1.7

20.4

458

2788

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

20.4

478

2946

J02AC01

ATC

fluconazole; systemic

1.2

20.4

2863

24254

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

8.0

20.4

R05

ICPC

Cough

1.3

20.3

1625

12801

51925

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis NUD

4.8

20.3

143

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.4

20.3

170

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

20.3

389

2260

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.6

20.2

151

591

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

20.2

412

2440

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.4

20.2

294

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.0

20.1

119

404

R06AE07

ATC

cetirizine; oral

1.2

20.1

3361

29018

A02BA02

ATC

ranitidine; systemic

1.3

20.1

1730

13773

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

20.1

727

4977

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

20.1

926

6660

ZXA10

NOMESCO Finland

Bilateral

1.3

20.1

1516

11843

I50.0

ICD-10 Finland

Congestive heart failure

1.5

20.0

721

4932

N05AH02

ATC

clozapine; systemic

2.6

20.0

148

575

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.7

20.0

136

503

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.4

20.0

291

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

20.0

445

2702

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.1

19.8

121

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

19.8

174

743

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

19.8

517

3276

J63.4

ICD-10 Finland

Siderosis

+∞

19.8

XG466

NOMESCO Finland

Sleep oxymetry

1.9

19.8

280

1466

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

19.7

373

2157

1242

FHL

Bronchoscopy and transbronchial lung apia

15.3

19.7

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

19.7

503

3173

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.9

19.6

121

423

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

19.6

2382

19825

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

19.6

634

4234

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

19.5

301

1629

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

19.5

302

E87.6

ICD-10 Finland

Hypokalaemia

2.0

19.5

248

1248

E86

ICD-10 Finland

Volume depletion

2.1

19.5

232

1136

J70.9

ICD-10 Finland

Respiratory conditions due to unspecified external agent

40.1

19.5

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

19.5

288

1535

R33

ICD-10 Finland

Retention of urine

1.5

19.4

743

5151

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

19.3

127

459

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

19.3

234

1156

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.5

19.2

253

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

19.2

296

1599

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

7.2

19.2

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.8

19.1

123

441

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

19.1

961

7020

C01BD01

ATC

amiodarone; systemic

1.9

19.0

268

1402

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

9.8

19.0

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

19.0

508

3242

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

18.9

519

3333

M04AA01

ATC

allopurinol; systemic

1.4

18.9

1173

8884

N30.0

ICD-10 Finland

Acute cystitis

1.4

18.9

1002

7389

N04AA02

ATC

biperiden; systemic

2.3

18.9

173

754

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

18.9

3826

33641

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

18.8

2088

17169

S18

ICPC

Laceration/cut

1.2

18.8

3455

30078

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.8

18.6

130

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

6.5

18.6

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.5

18.6

149

606

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

18.5

586

3892

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

18.5

595

3968

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

18.4

619

4169

N05AB03

ATC

perphenazine; systemic, rectal

1.9

18.3

279

1505

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

18.3

290

1586

N06AB06

ATC

sertraline; oral

1.5

18.2

730

5109

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

18.1

613

4135

M79.6

ICD-10 Finland

Pain in limb

1.2

18.1

2763

23561

N18

ICPC

Paralysis/weakness

2.3

18.1

173

770

1243

FHL

Bronchoscopy and other therapeutic procedure

10.3

18.1

A03

ICPC

Fever

1.4

18.0

1025

7653

R4190

NOMESCO Finland

Nutritional therapy

2.0

17.9

240

1235

N05AF03

ATC

chlorprothixene; systemic

2.1

17.9

209

1019

R05FB02

ATC

cough suppressants and expectorants

1.2

17.8

3250

28227

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

17.8

179

816

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

17.8

5272

47982

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

17.7

872

6349

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.1

17.6

195

926

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

17.6

252

1328

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.5

17.6

143

588

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

17.5

791

5664

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

17.5

497

3220

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.1

17.5

317

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

2.6

17.5

128

495

J20

ICD-10 Finland

Acute bronchitis

1.5

17.4

683

4755

WX402

NOMESCO Finland

General anaesthesia

1.3

17.3

1182

9080

D07AC13

ATC

mometasone; topical

1.2

17.2

2299

19294

TK800

NOMESCO Finland

Hemodialysis

2.1

17.2

192

916

J01FA10

ATC

azithromycin; systemic

1.2

17.2

4513

40562

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

17.2

459

2931

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

17.1

478

3085

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

17.1

2670

22802

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

17.0

332

1941

XG460

NOMESCO Finland

Short time oxymetry

2.2

17.0

168

762

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

16.9

335

SPAT1240

SPAT

Therapeutic discussion

1.5

16.9

642

4437

N03AX18

ATC

lacosamide; systemic

3.8

16.9

192

Z94.2

ICD-10 Finland

Lung transplant status

9.5

16.8

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.0

16.8

310

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

16.8

456

2923

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

16.7

584

3969

J64

ICD-10 Finland

Unspecified pneumoconiosis

+∞

16.7

R99

ICPC

Respiratory disease other

2.3

16.6

147

632

5CM18

NOMESCO Finland

4.9

16.6

111

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.7

16.6

313

1812

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

15.0

16.6

M25.5

ICD-10 Finland

Pain in joint

1.3

16.6

2064

17174

R01AD09

ATC

mometasone; nasal

1.2

16.6

3420

30019

R42

ICD-10 Finland

Dizziness and giddiness

1.3

16.4

1762

14399

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

16.4

514

3406

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

16.4

3225

28163

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.4

16.3

234

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

16.3

2024

16832

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

16.3

141

599

A01AB09

ATC

miconazole; local oral

1.4

16.3

697

4936

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

16.2

225

1173

GD1LA

NOMESCO Finland

2.4

16.2

137

574

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.0

16.2

317

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

16.2

305

1763

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

16.2

488

3208

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

16.1

1937

16040

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

8.7

16.1

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

16.1

365

2232

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

5.6

16.1

RS220

NOMESCO Finland

2.6

16.0

114

437

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.9

15.9

343

WW200

NOMESCO Finland

Immunization

1.9

15.9

220

1145

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

15.9

283

1610

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

15.9

301

1746

N05AD01

ATC

haloperidol; systemic

1.8

15.9

275

1548

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.9

15.9

104

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

9.4

15.9

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

15.8

1969

16372

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

15.8

3127

27306

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

15.8

1084

8333

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.8

15.8

102

369

N07BB01

ATC

disulfiram; oral

1.7

15.7

327

1950

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.3

15.7

242

5188X

ICD-9 Finland

Other diseases of lung

5.2

15.6

R4120

NOMESCO Finland

Occupational therapy

1.5

15.6

467

3065

4958X

ICD-9 Finland

Extrinsic allergic alveolitis, Other specified allergic alveolitis and pneumonitis

+∞

15.6

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

15.6

817

6004

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

15.6

418

2670

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

15.5

832

6141

N29

ICPC

Neurological sympt/complt other

2.2

15.5

155

705

J01FA15

ATC

telithromycin; oral

1.4

15.5

724

5212

GX1K5

NOMESCO Finland

Diffusion capacity

7.8

15.5

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

15.5

157

719

JAH00

NOMESCO Finland

Laparotomy

1.9

15.4

225

1198

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.1

15.4

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

15.3

1160

9044

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

15.3

342

AN1

Coronary angiography

1.3

15.3

1037

7955

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.5

15.3

122

499

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

15.2

488

3251

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.3

15.2

143

634

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

15.2

467

3083

N99

ICPC

Neurological disease other

2.7

15.2

103

383

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

15.2

125

519

E66.8

ICD-10 Finland

Other obesity

1.7

15.2

331

2003

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.7

15.2

100

367

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

15.2

145

648

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.0

15.2

184

912

A04AA02

ATC

granisetron; systemic, transdermal

1.6

15.2

429

2776

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.7

15.1

285

1653

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.4

15.1

131

560

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

15.1

279

1608

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

15.1

1022

7839

GDA10

NOMESCO Finland

Biopsy of lung

6.6

15.0

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

15.0

310

1845

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

15.0

169

813

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

15.0

2070

17401

UKC02

NOMESCO Finland

Cystoscopy

1.3

15.0

1419

11405

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

14.9

156

726

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

14.9

2256

19154

M03BX01

ATC

baclofen; systemic

2.3

14.9

134

581

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

14.8

247

1379

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.6

14.7

106

410

SPAT1310

SPAT

Counselling related to known health issue

1.2

14.7

2462

21115

RS221

NOMESCO Finland

2.4

14.7

127

541

N05AN01

ATC

lithium; oral

2.0

14.6

175

863

J68.4

ICD-10 Finland

Chronic respiratory conditions due to chemicals, gases, fumes and vapours

+∞

14.6

M63.3*D86.8

ICD-10 Finland

Myositis in sarcoidosis

+∞

14.6

A29

ICPC

General symptom/complaint other

1.4

14.6

841

6284

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

14.6

209

1104

G51.0

ICD-10 Finland

Bell palsy

1.9

14.5

197

1021

I51.4

ICD-10 Finland

Myocarditis, unspecified

3.8

14.5

157

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.7

14.5

282

1651

P76

ICPC

Depressive disorder

1.6

14.4

358

2243

L04AA01

ATC

[U] ciclosporin; systemic

2.4

14.4

120

502

B01AB10

ATC

tinzaparin; parenteral

1.5

14.4

512

3492

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

15.4

14.4

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

14.4

485

3272

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

14.3

223

1213

K92.0

ICD-10 Finland

Haematemesis

1.9

14.3

215

1158

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

4.6

14.2

104

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

14.2

241

1350

49300

ICD-8 Finland

Asthma, bronchiale

1.9

14.1

204

1082

SPAT1104

SPAT

Monitoring of emergency patient

1.5

14.1

517

3549

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

4.2

14.1

123

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

14.1

544

3780

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

14.1

187

964

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

14.0

120

508

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.2

14.0

230

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

14.0

171

853

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

5.8

14.0

T90

ICPC

Diabetes non-insulin dependent

1.2

14.0

1855

15515

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

14.0

164

805

N05BA12

ATC

alprazolam; oral

1.4

13.9

743

5480

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

13.9

857

6473

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

13.9

233

1300

Z72.2

ICD-10 Finland

Drug use

4.6

13.9

102

R01AD01

ATC

beclometasone; nasal

1.3

13.8

1111

8731

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

13.8

674

4892

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.6

13.8

335

2085

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.7

13.8

271

1592

C07AB02

ATC

metoprolol; systemic

1.2

13.8

1851

15495

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

13.8

124

539

N19

ICPC

Speech disorder

2.6

13.7

101

394

WW500

NOMESCO Finland

Blood transfusion

1.7

13.7

304

1847

K56.0

ICD-10 Finland

Paralytic ileus

2.6

13.7

367

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

7.3

13.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

13.6

144

673

SPAT1153

SPAT

Removal of sutures

1.2

13.6

2545

22039

C08CA01

ATC

amlodipine; oral

1.2

13.6

3039

26752

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

13.6

221

1222

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

858

2068

4.40

323.01

1.6

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7435

52544

2.13

322.61

12.4

8.9

e9/l

4.4

4.2

5.99

6783

45582

(3001604) Monocytes [#/volume] in Blood

6939

45375

2.29

307.65

8.7

5.7

e9/l

0.6

2.96

6283

38814

(42870588) Differential panel, method unspecified - Blood

5267

31250

2.24

307.65

8.5

5.8

—

(3019198) Lymphocytes [#/volume] in Blood

7026

46618

2.26

307.65

8.9

5.7

e9/l

1.7

1.9

16.29

6406

40628

(3006315) Basophils [#/volume] in Blood

6973

45622

2.30

307.65

8.7

5.7

e9/l

0.0

0.19

6312

39024

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3142

3267

12.76

307.65

5.3

1.2

u/l

44.7

37.8

37.31

2979

2791

(3013115) Eosinophils [#/volume] in Blood

7095

47102

2.28

307.65

9.2

5.9

e9/l

0.2

0.12

6474

40928

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6568

42467

2.24

307.65

9.1

6.0

mmol/l

1.2

0.75

6161

38316

(3018010) Neutrophils/100 leukocytes in Blood

6488

43199

2.12

307.65

8.9

5.8

59.9

57.8

40.52

6217

40106

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1258

3293

4.16

307.65

2.6

2.7

—

(3019069) Monocytes/100 leukocytes in Blood

6528

42884

2.17

307.65

9.5

6.2

9.0

8.7

10.92

6263

39888

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7095

46910

2.29

307.65

10.2

6.7

mmol/l

1.2

1.93

5937

39406

(3006504) Eosinophils/100 leukocytes in Blood

6507

42654

2.18

307.65

9.1

5.9

3.0

2.9

2.35

6235

39490

(3002030) Lymphocytes/100 leukocytes in Blood

6577

43898

2.13

307.65

9.3

6.0

24.7

27.2

68.84

6295

40581

(3022096) Basophils/100 leukocytes in Blood

6409

41415

2.20

307.65

9.1

6.0

0.7

0.35

6154

38377

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2374

1997

14.64

307.65

4.9

1.3

mg/l

11.0

11.7

1.15

2302

1834

(3018418) pH of Serum or Plasma

4616

27684

2.10

307.35

5.6

4.1

7.4

1.74

1066

5302

(3023368) Bacteria identified in Blood by Culture

4448

26953

2.05

282.00

5.7

4.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

338

392

8.85

267.72

1.5

1.7

mmol/24h

5.8

6.6

0.32

(3042631) Mycobacterium sp identified in Specimen

587

1335

4.58

236.88

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

548

1182

4.81

236.00

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6704

48679

1.88

232.64

7.8

6.1

umol/l

11.5

11.8

1.10

6433

46093

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1096

3981

2.93

218.06

1.5

1.6

u/ml

16.6

15.5

0.07

108

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1719

7937

2.37

209.39

2.4

2.2

nmol/l

349.5

374.2

4.53

1606

7264

(3032080) INR in Blood by Coagulation assay

5594

39501

1.79

201.22

11.7

9.9

inr

1.3

0.72

1719

11095

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

262

320

8.35

198.88

6.5

1.6

ug/l

82.5

200.5

0.44

256

295

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4367

28750

1.83

197.60

4.6

3.1

ng/l

1559.0

1681.4

1.10

3832

24716

(3023419) Bacteria identified in Sputum by Culture

492

1147

4.43

192.02

2.9

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1478

6642

2.40

190.26

3.0

2.6

g/l

10.5

10.6

0.41

1360

6050

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

343

620

5.67

180.22

1.7

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2728

15867

1.94

179.01

2.3

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2652

15304

1.95

178.01

4.8

3.2

mmol/l

0.8

2.01

2495

14217

(3024561) Albumin [Mass/volume] in Serum or Plasma

5663

41090

1.73

177.07

6.1

4.8

g/l

34.2

35.2

25.44

5257

37951

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

352

668

5.40

175.40

2.0

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

691

2193

3.29

172.48

1.9

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

673

2109

3.32

171.46

1.9

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

862

3135

2.89

169.84

1.7

1.6

titre

329.4

234.6

0.40

138

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8658

71272

1.82

168.11

10.9

7.5

u/l

80.9

79.4

1.94

8319

66954

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2247

12514

1.98

165.93

7.1

5.8

mmol/l

1.0

0.43

2098

11570

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5151

36872

1.71

165.40

5.6

3.8

ng/l

39.3

74.6

2.00

3983

26247

(3037522) Nuclear Ab [Titer] in Serum

2115

11581

2.01

163.69

1.4

1.3

titre

498.2

530.8

0.36

480

2406

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

555

1610

3.57

159.42

1.7

1.4

—

(3003396) Base excess in Arterial blood by calculation

2053

11310

1.99

155.37

9.6

7.0

mmol/l

1.5

1.0

5.39

1642

8714

(3015377) Calcium [Moles/volume] in Serum or Plasma

4479

31293

1.70

154.23

3.8

3.4

mmol/l

2.3

2.4

2.53

3971

27052

(3013707) Erythrocyte sedimentation rate by Westergren method

8203

67186

1.73

153.58

6.4

4.0

mm/h

14.9

12.8

25.10

7778

61855

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

977

3993

2.58

152.85

2.4

1.9

ug/l

2.5

2.2

0.21

870

3485

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2035

11350

1.96

147.89

9.7

7.0

kpa

5.1

2.55

1912

10779

(3027801) Oxygen [Partial pressure] in Arterial blood

2031

11347

1.95

146.75

9.7

7.0

kpa

11.2

12.2

14.49

1914

10757

(3009343) pH of Capillary blood

1291

6132

2.24

143.83

4.8

3.5

7.4

0.20

197

758

(3036603) Volume of Urine

299

587

5.20

143.34

2.0

1.6

1898.3

1891.2

0.02

158

(3013826) Glucose [Moles/volume] in Serum or Plasma

6964

55151

1.64

142.59

7.4

4.7

mmol/l

6.9

6.8

2.23

6645

51740

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1299

6222

2.22

141.67

4.9

3.5

kpa

5.2

5.1

2.86

1217

5703

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1253

5918

2.25

141.40

4.8

3.5

mmol/l

2.3

1.7

6.38

978

4327

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

461

1284

3.70

140.57

1.7

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

520

1572

3.41

139.93

1.9

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1136

5203

2.31

137.78

1.8

g/l

1.2

1.4

2.06

1039

4705

(3019060) Gas panel - Arterial blood

1338

6594

2.16

135.56

6.4

4.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

441

1235

3.67

133.34

1.8

1.5

—

(3011412) CD3 cells [#/volume] in Blood

343

808

4.34

131.79

2.3

2.4

e9/l

1.0

1.2

1.91

231

495

(3005322) IgE [Units/volume] in Serum or Plasma

1087

4982

2.30

131.37

1.5

1.3

u/ml

209.1

232.7

0.31

993

4600

(40760892) CBC W Ordered Manual Differential panel - Blood

3005

19521

1.72

130.73

6.7

4.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1647

8887

1.99

130.32

9.2

7.1

mmol/l

10.1

10.5

1.65

1565

8408

(3017181) Myelocytes/100 leukocytes in Blood

1503

7855

2.05

130.04

4.7

4.0

0.9

0.11

509

2288

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

432

1234

3.60

126.77

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1905

10899

1.89

126.34

2.2

1.8

—

(3016502) Oxygen saturation in Arterial blood

1802

10150

1.92

125.27

10.4

7.4

94.8

95.5

4.52

1715

9752

(3002179) Metamyelocytes/100 leukocytes in Blood

1379

7119

2.06

122.96

4.5

3.9

0.7

0.6

0.52

387

1646

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1886

10904

1.87

120.54

2.2

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4105

29381

1.61

120.48

4.2

3.2

u/l

34.4

35.1

0.26

3876

27721

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

461

1420

3.34

120.25

1.6

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

1411

7469

2.01

117.05

4.8

4.1

0.1

1.12

475

2126

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1334

6958

2.03

115.21

1.8

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

369

1011

3.74

115.13

1.9

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

531

1841

2.97

113.31

1.3

1.2

titre

354.5

109.2

0.51

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4889

36824

1.56

113.20

2.7

2.2

nmol/l

75.3

77.7

7.29

4435

32783

(3042936) Bacteria identified in Isolate by Culture

2187

13461

1.77

112.92

2.4

2.0

—

(3025159) Blasts/100 leukocytes in Blood

1330

6989

2.02

112.35

4.8

4.1

0.2

0.02

417

1782

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1907

11288

1.82

112.26

4.0

4.1

u/l

246.0

245.6

0.04

1796

10614

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4053

29347

1.58

110.93

3.1

2.6

u/l

57.7

58.5

0.33

3777

27032

(1175426) CD3 cells/100 lymphocytes in Blood

280

644

4.43

110.90

2.1

2.0

70.8

72.4

0.72

264

616

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

455

1465

3.19

110.31

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

647

2529

2.65

109.99

1.5

1.4

iu/ml

8.6

14.3

0.72

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4014

29062

1.58

109.57

2.9

2.2

u/l

234.1

220.7

0.25

3791

27177

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

274

632

4.41

108.13

2.1

2.0

15.0

14.8

0.06

110

275

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2344

14928

1.71

106.41

2.4

2.1

30.1

30.0

0.07

2269

14464

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

264

602

4.46

105.71

2.2

2.1

—

(3021589) Normoblasts [#/volume] in Blood

5160

39805

1.53

104.31

15.2

9.8

e9/l

0.0

0.68

4393

32400

(3023183) Ammonium ion [Moles/volume] in Plasma

528

1941

2.80

101.05

2.7

umol/l

32.5

34.2

0.71

463

1626

(1616796) Gas panel - Central venous blood

574

2209

2.68

100.53

4.2

3.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1186

6239

2.00

99.25

9.8

6.9

mmol/l

25.1

24.5

5.42

1102

5819

(3006184) Hemoglobin [Mass/volume] in Capillary blood

570

2219

2.65

97.53

2.2

g/l

131.1

128.3

1.39

342

1616

(4010399)

1213

6518

1.96

95.30

1.7

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1579

9251

1.82

94.81

11.4

7.8

g/l

121.3

121.1

0.14

1512

8922

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

416

4.95

92.60

1.3

1.1

u/l

1.2

1.1

1.13

108

190

(3022948) Iron [Moles/volume] in Serum or Plasma

2335

15354

1.65

92.18

2.9

2.5

umol/l

12.1

12.7

4.39

2161

14145

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1487

8625

1.83

92.08

4.4

3.0

ng/l

210.2

226.4

0.70

1357

7848

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1385

7860

1.86

91.99

5.0

3.9

mmol/l

1.2

0.50

1277

6847

(3037692) Legionella sp identified in Specimen by Organism specific culture

171

303

5.71

91.71

1.6

1.4

—

(3022313) Gas panel - Capillary blood

909

4463

2.12

91.47

5.2

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

628

2641

2.46

91.37

1.6

iu/ml

0.3

8.6

1.76

141

607

(3026782) Osmolality of Urine

2762

18964

1.60

91.28

3.4

2.8

mosm/kgh2o

533.3

553.7

6.01

2448

16131

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2186

14257

1.66

88.71

2.9

2.5

g/l

2.3

0.19

2021

13144

(3024980) IgG subclass 4 [Mass/volume] in Serum

408

1399

2.99

88.63

1.6

g/l

0.9

0.8

0.37

294

1075

(3000850) Epithelial cells [#/volume] in Urine

2904

20313

1.57

88.08

3.3

2.6

e6/l

5.2

4.8

0.69

2643

17764

(3010421) pH of Blood

614

2604

2.43

87.64

5.2

4.1

7.4

1.25

537

2213

(40758558) Short blood count panel - Blood

3219

23075

1.54

87.39

9.3

6.7

—

(3010503) CD19 cells [#/volume] in Blood

224

522

4.35

87.25

2.3

2.6

e9/l

0.5

0.3

0.23

218

504

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2063

13344

1.66

86.18

3.0

2.6

21.2

22.3

3.14

1759

11288

(3037467) Urinalysis macro (dipstick) panel - Urine

7401

62875

1.48

85.19

5.6

4.4

—

(3018133) Calcium [Moles/volume] in Urine

101

109

9.34

84.44

2.5

1.4

mmol/l

2.9

2.4

1.00

(21494815) CD4 cells/100 lymphocytes in Specimen

266

723

3.74

83.92

2.1

2.3

35.8

41.1

1.06

(46235355) HIV 1 and 2 tests - Meaningful Use set

1920

12277

1.67

83.58

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

3859

29019

1.49

82.39

4.1

3.3

e6/l

74.6

106.6

0.96

3177

22466

(3027315) Oxygen [Partial pressure] in Blood

549

2278

2.48

82.11

5.3

4.1

kpa

8.2

8.6

6.54

539

2220

(3012501) Base excess in Blood by calculation

547

2266

2.48

82.10

5.3

4.1

mmol/l

2.7

2.5

1.00

418

1523

(3013290) Carbon dioxide [Partial pressure] in Blood

547

2267

2.48

82.02

5.3

4.1

kpa

5.0

0.49

537

2210

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

465

1786

2.67

81.59

7.6

5.4

iu/ml

374.9

2105.7

1.04

259

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

155

281

5.58

81.15

2.0

1.9

—

(44790049)

315

978

3.28

80.99

1.9

1.4

—

(44806118)

315

978

3.28

80.99

1.9

1.4

—

(44790048)

315

978

3.28

80.99

1.9

1.4

—

(44790047)

315

978

3.28

80.99

1.9

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1060

5757

1.92

80.05

9.2

7.0

mmol/l

25.1

24.7

2.39

1050

5704

(3031040) Bacteria [#/volume] in Urine by Automated count

7112

60303

1.45

80.00

5.8

4.6

e6/l

1330.8

1671.8

0.29

157

925

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2694

18887

1.55

79.57

5.7

3.9

ng/l

362.6

506.3

1.09

2171

15230

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

221

557

4.02

77.58

2.3

2.6

e6/l

409.5

524.8

2.68

189

470

(4062490)

289

874

3.36

77.52

1.4

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

289

874

3.36

77.52

1.4

1.3

g/l

6.9

6.8

0.19

194

620

(3024139) IgG subclass 3 [Mass/volume] in Serum

289

874

3.36

77.52

1.4

1.3

g/l

0.4

1.42

196

623

(3028192) IgG subclass 2 [Mass/volume] in Serum

289

875

3.36

77.38

1.4

1.3

g/l

3.1

2.9

0.84

196

626

(3002032) Base excess in Venous blood by calculation

1493

9097

1.73

77.20

5.0

3.9

mmol/l

2.2

1.9

3.14

1246

7335

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1497

9130

1.73

77.14

5.0

3.8

kpa

5.9

5.8

2.01

1434

8843

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2804

19953

1.53

76.97

2.1

1.7

mg/l

1.4

1.3

0.63

2212

15367

(3014111) Lactate [Moles/volume] in Serum or Plasma

1419

8583

1.74

75.18

9.4

6.7

mmol/l

1.5

1.4

1.69

1360

8212

(3012544) pH of Venous blood

1532

9480

1.71

74.72

5.0

3.8

7.4

0.03

(3000494) Fungus identified in Specimen by Culture

1666

10574

1.67

73.79

1.8

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

503

2106

2.45

73.70

3.0

2.5

16.5

16.1

0.99

270

1085

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1027

5695

1.88

72.49

1.7

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

256

749

3.47

72.33

1.7

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

523

2251

2.38

72.07

4.2

3.0

kpa

8.1

8.0

0.66

493

2071

(3018095) Leukocytes [#/volume] in Urine

4246

33205

1.44

71.15

4.7

3.8

e6/l

103.0

101.3

0.03

3335

24071

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

208

536

3.93

70.83

2.4

2.7

e9/l

0.2

1.42

188

465

(3007853) Bacteria identified in Skin by Aerobe culture

1709

11050

1.64

70.09

2.1

1.8

—

(36304419) Bacteria [Presence] in Urine

3398

25558

1.46

69.77

3.8

3.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

753

3804

2.05

69.70

5.8

3.8

mmol/l

25.4

24.8

6.22

696

3456

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

598

3.73

69.43

1.6

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

565

2555

2.27

69.41

3.6

3.1

mmol/l

25.1

24.7

1.16

515

2214

(3020630) Protein [Mass/volume] in Serum or Plasma

1357

8286

1.72

69.13

2.2

2.4

g/l

66.2

66.3

0.20

1244

7460

(3000991) Gas panel - Venous blood

1335

8125

1.73

68.80

11.2

8.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

521

3.93

68.71

1.7

1.5

—

(3016228) CD19 cells/100 cells in Blood

161

354

4.60

67.53

2.1

2.0

8.7

8.2

0.21

155

344

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

200

520

3.90

67.27

1.7

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1411

8769

1.69

67.24

2.7

2.2

g/l

0.2

0.57

1291

8112

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3241

24305

1.46

67.03

2.6

2.3

mg/l

3.3

3.0

7.03

2815

20654

(3030467) Casts [#/volume] in Urine by Automated count

3484

26491

1.45

66.96

3.9

3.2

e6/l

0.5

0.05

2811

20117

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

687

3418

2.07

66.22

3.1

2.3

ug/l

444.6

639.0

1.00

645

3231

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

282

938

3.06

64.59

1.9

1.7

—

(3021901) Oxygen saturation in Capillary blood

443

1862

2.43

64.30

3.2

2.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

155

344

4.55

64.28

2.1

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

280

935

3.04

63.70

3.7

3.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2254

15886

1.52

62.85

1.7

1.5

g/l

2.6

2.5

0.55

1485

9599

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

266

873

3.09

62.36

2.0

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4673

37785

1.39

62.15

3.6

2.8

ug/l

158.7

145.7

1.15

4288

34666

(3012565) Volume of 24 hour Urine

175

440

4.02

61.69

1.8

2.3

2038.5

1900.9

0.76

162

379

(3015171) Extractable nuclear Ab [Units/volume] in Serum

648

3241

2.06

61.50

1.2

u/ml

0.5

1.0

1.42

315

(3014576) Chloride [Moles/volume] in Serum or Plasma

1815

12255

1.57

61.37

10.2

6.9

mmol/l

104.1

104.5

2.62

1759

12003

(3033658) Prothrombin time (PT) actual/Normal

3141

23770

1.44

60.69

5.2

4.0

87.2

87.7

0.44

3060

23157

(3000492) Spirometry study

1316

8245

1.67

60.41

2.0

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

914

5191

1.82

59.35

11.8

8.9

mmol/l

24.6

24.3

2.26

850

4782

(3024354) Oxygen [Partial pressure] in Venous blood

1215

7496

1.69

59.05

4.1

3.2

kpa

4.7

4.5

1.58

1156

7230

(3044290) Cell count panel - Cerebral spinal fluid

405

1701

2.43

58.87

1.6

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1692

11389

1.57

57.68

3.0

2.4

1.8

1.98

1474

9977

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1506

9876

1.60

57.39

4.6

3.5

—

(3026008) Bacteria identified in Urine by Culture

3567

27828

1.40

57.38

3.8

3.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

181

492

3.72

57.17

4.2

3.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

342

1350

2.58

56.72

3.5

2.6

u/ml

23582.3

1745.8

0.45

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

472

2153

2.24

56.69

1.2

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1393

9009

1.62

56.14

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1595

10681

1.57

55.43

2.9

2.7

umol/l

8.2

8.8

0.61

1377

9271

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

421

1856

2.32

54.83

1.4

1.3

mmol/l

3.9

3.8

1.02

392

1739

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

462

2118

2.23

54.81

1.5

1.3

mg/l

658.3

537.1

0.82

436

2005

(3028271) Lactate [Moles/volume] in Capillary blood

375

1574

2.43

54.58

2.5

1.9

mmol/l

1.7

0.04

368

1540

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

522

2522

2.12

54.25

1.6

g/l

0.2

0.48

502

2383

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

253

4.82

54.00

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1142

7091

1.68

53.93

4.2

3.9

ng/l

89.7

94.6

0.82

988

6055

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

534

2612

2.09

53.72

1.7

1.6

g/l

1.2

0.30

512

2474

(3018405) Lactate [Moles/volume] in Arterial blood

658

3494

1.94

52.55

5.6

4.0

mmol/l

1.5

1.4

0.86

642

3435

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

559

3.40

51.88

1.2

1.1

—

(3019225) pH of Specimen

1418

9376

1.58

51.81

6.2

4.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2552

19056

1.43

51.59

2.0

1.8

nmol/l

1189.5

1159.2

0.88

1941

14322

(40768795) Lymph node Pathology biopsy report

250

884

2.87

51.38

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

657

3515

1.92

51.29

3.6

3.0

u/ml

0.3

0.04

393

2001

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

525

2602

2.07

50.96

2.0

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

3690

29390

1.37

50.93

3.0

2.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.41

50.73

2.2

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

201

632

3.22

50.70

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1098

6859

1.66

50.52

2.0

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1525

10338

1.55

49.78

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

184

559

3.33

49.09

1.6

1.3

u/ml

2.4

1.3

0.61

111

259

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

994

6108

1.69

48.63

13.0

8.8

0.7

0.06

981

6066

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2023

14603

1.47

48.61

1.3

iu/ml

33.5

35.8

0.26

651

4567

(3028707) Methadone [Presence] in Urine by Screen method

263

984

2.71

48.58

4.7

2.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

193

612

3.19

48.02

1.2

mg/l

52.8

42.3

0.45

158

510

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

554

2885

1.97

46.79

1.8

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

881

5295

1.72

46.73

14.6

9.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

986

6133

1.66

45.95

12.9

8.7

1.4

1.52

972

6093

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

401

1870

2.18

45.59

1.5

1.4

e6/l

52.9

22.5

0.46

311

1452

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

184

586

3.17

45.47

1.1

mg/l

338.1

283.4

0.61

161

511

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

401

1872

2.18

45.47

1.6

1.4

e6/l

467.8

1214.7

2.21

327

1534

(4027681)

155

445

3.52

45.20

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

123

302

4.11

44.87

2.2

2.1

11.6

10.2

0.44

109

278

(3009466) Valproate [Moles/volume] in Serum or Plasma

306

1286

2.42

44.43

5.5

4.7

umol/l

349.1

358.2

0.50

271

1102

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

120

6.20

43.57

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

222

806

2.79

43.48

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

222

806

2.79

43.48

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

222

806

2.79

43.48

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

5214

44422

1.31

43.45

4.6

3.7

estimate

0.0

1.08

1225

8065

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

779

4616

1.74

43.40

5.2

4.1

mmol/l

24.4

24.1

1.39

709

4129

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5032

42671

1.31

43.36

4.9

4.1

—

(3009261) Glucose [Presence] in Urine by Test strip

5271

44991

1.31

43.27

4.6

3.8

estimate

0.0

0.98

1184

7968

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

361

1648

2.23

43.26

1.4

u/ml

18.7

18.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

185

610

3.07

43.12

2.2

2.7

e6/l

469.8

673.1

3.89

239

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

354

1608

2.24

42.94

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2307

17453

1.40

42.07

3.3

3.1

mmol/l

2.5

4.30

2015

15125

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

360

1662

2.20

41.97

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

565

3079

1.88

41.58

8.8

6.0

mmol/l

1.3

0.21

482

2721

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

119

302

3.97

41.53

2.1

27.0

29.4

0.97

110

284

(3043409) Potassium [Moles/volume] in Arterial blood

549

2974

1.89

41.16

6.1

4.2

mmol/l

3.9

0.10

492

2798

(3021601) Nitrite [Presence] in Urine by Test strip

5198

44476

1.30

41.12

6.0

5.0

estimate

0.0

0.63

1231

8213

(4035726)

1213

8169

1.54

40.26

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

927

5871

1.63

40.04

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

441

2251

2.00

39.42

1.3

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

1252

8534

1.52

39.25

2.7

2.5

e9/l

72.4

68.9

2.34

970

6504

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

328

1499

2.22

39.22

1.3

1.2

u/ml

281.6

276.5

0.12

211

942

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

324

1476

2.23

39.05

1.5

u/ml

105.0

121.4

1.49

323

(40761536) Microorganisms panel - Urine sediment

1140

7637

1.55

38.68

4.9

4.0

—

(3020891) Body temperature

669

3921

1.75

38.67

7.0

4.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

117

309

3.81

38.64

1.7

1.9

u/ml

2289.7

42935.3

0.67

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

18.28

38.62

1.1

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

783

4808

1.67

38.14

4.5

3.5

mmol/l

25.5

25.1

2.13

746

4654

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

508

2754

1.88

37.98

7.0

1.5

mg/l

5.2

3.7

1.41

458

1956

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

200

739

2.74

37.93

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

904

5775

1.61

37.63

2.0

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

459

2417

1.94

37.48

1.2

titre

88.2

161.6

1.57

213

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9697

90858

1.38

37.39

26.8

15.2

mg/l

24.8

25.3

0.99

8724

73077

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

477

2559

1.90

36.83

3.2

2.5

g/l

3.7

3.6

0.50

461

2428

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1845

13714

1.41

36.70

1.3

u/ml

11.4

13.0

0.42

655

5238

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

837

5304

1.62

35.97

1.3

au/ml

63.8

53.3

0.38

236

(4198724)

107

280

3.85

35.83

3.7

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2996

24129

1.32

35.56

5.1

4.2

estimate

0.0

2.80

1151

7809

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6608

58928

1.28

35.48

4.4

3.1

u/l

64.2

51.0

14.46

6163

54535

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

902

5840

1.59

35.43

2.4

au/ml

26.6

25.0

0.07

304

(3034770) Mitochondria Ab [Titer] in Serum

451

2406

1.91

35.42

1.2

titre

890.7

858.4

0.04

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

519

2897

1.83

35.36

1.4

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3115

25265

1.32

35.07

3.3

2.7

umol/l

2632.7

4893.5

3.37

2675

21718

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1267

8852

1.48

35.02

2.7

2.4

ug/l

9.6

7.3

1.50

1091

7605

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

189

709

2.69

34.84

1.2

titre

149.0

186.8

0.34

134

(3004119) Hemoglobin [Mass/volume] in Venous blood

912

5943

1.58

34.83

4.5

3.4

g/l

126.3

128.7

2.48

880

5801

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4083

34422

1.29

34.09

4.9

4.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

355

1767

2.04

34.06

1.2

u/ml

17.8

17.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

376

3.35

34.01

1.6

1.9

umol/l

75.5

133.2

1.65

198

(3004809) Band form neutrophils/100 leukocytes in Blood

333

1621

2.08

33.93

3.3

3.5

1.3

1.6

0.96

279

1232

(3020191) Ethanol [Moles/volume] in Serum or Plasma

192

737

2.63

33.83

1.7

1.4

promille

1.2

1.3

0.46

145

567

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

675

4121

1.68

33.54

2.3

2.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

347

1745

2.02

32.37

1.2

u/ml

3.0

3.6

0.14

125

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

671

4130

1.66

32.31

7.7

5.1

1.7

1.6

1.04

608

3878

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

427

2307

1.88

32.26

1.3

u/ml

24.2

38.3

0.75

136

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

198

790

2.53

32.25

2.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

280

1301

2.18

32.19

7.7

6.3

mg/l

11.7

0.05

251

1195

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

202

816

2.50

32.06

1.7

1.4

—

(3013512) EKG study

3335

27604

1.29

31.56

4.9

4.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

660

4073

1.66

31.44

7.8

5.2

0.9

1.76

597

3832

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

620

3771

1.68

31.23

2.1

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

535

3126

1.75

31.21

2.6

3.0

ratio

14.8

3.1

0.50

246

(3028433) Virus identified in Specimen by Culture

105

299

3.53

31.13

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

546

3218

1.73

30.88

2.6

3.0

mg/l

70.1

77.2

0.12

403

2600

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

190

761

2.52

30.72

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

545

3217

1.73

30.66

2.6

3.0

mg/l

44.1

47.4

0.19

403

2600

(3041096) Erythrocytes [Presence] in Urine by Automated

2919

23851

1.30

30.25

4.2

3.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

438

2437

1.83

30.16

2.5

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1796

13694

1.37

30.06

26.4

27.2

inr

1.4

0.09

219

1932

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2751

22346

1.30

29.71

2.9

2.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

170

4.37

29.57

1.7

2.2

—

(3039000) Anion gap in Blood

404

2207

1.86

29.50

10.3

7.0

mmol/l

10.9

11.3

1.54

350

1988

(3018572) Chloride [Moles/volume] in Blood

404

2208

1.86

29.46

10.3

7.0

mmol/l

104.7

105.1

0.86

350

1989

(3016018) Differential panel - Cerebral spinal fluid

207

884

2.37

29.12

1.7

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

715

4588

1.59

29.05

3.8

2.8

1.3

1.2

0.73

710

4557

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

123

405

3.06

28.88

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

388

2108

1.87

28.83

1.2

1.3

u/ml

2.1

4.7

1.07

212

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

437

2.97

28.83

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

395

2164

1.85

28.59

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

395

2164

1.85

28.59

1.5

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

391

2136

1.86

28.56

1.3

u/ml

7.8

6.6

0.15

334

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

718

4660

1.58

27.77

1.8

1.7

g/l

1.6

1.5

0.64

591

3950

(3019977) pH of Arterial blood

150

564

2.68

27.62

3.3

2.6

7.4

0.21

195

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

433

2.93

27.47

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

139

509

2.75

26.95

2.6

2.7

42.6

37.2

1.73

167

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

255

3.55

26.95

2.6

3.3

—

(4015189)

260

3.52

26.90

2.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

760

5036

1.54

26.80

3.3

3.2

pmol/l

4.3

4.4

1.82

674

4450

(1001926) Buprenorphine [Presence] in Urine by Screen method

332

1765

1.91

26.40

3.8

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

489

2930

1.70

26.05

3.9

3.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

994

2.21

25.93

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

225

1046

2.17

25.91

4.4

4.0

—

(40757373) Influenza virus identified in Isolate

184

3.99

25.86

1.9

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

211

3.76

25.81

2.0

2.2

e6/l

227.1

717.1

0.75

118

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

688

4497

1.56

25.78

3.7

2.8

0.7

1.55

671

4299

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2515

20607

1.28

24.65

1.8

1.7

pmol/l

9237991.3

28898507.2

2.46

2046

16925

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

678

4468

1.55

24.49

4.8

4.1

49.0

47.8

0.56

664

4413

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

451

2689

1.70

24.47

2.9

2.2

91.4

90.7

0.27

428

2516

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

141

4.34

24.24

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

271

1389

1.97

24.04

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

198

902

2.22

24.01

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

231

1120

2.08

23.90

8.2

13.1

mmol/l

7.5

7.6

0.14

195

916

(3051651) Icteric interference index of Serum or Plasma

146

584

2.52

23.78

4.4

3.8

—

(40768797) Stomach Pathology biopsy report

1620

12581

1.33

23.53

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

460

2.71

23.51

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

172

746

2.32

23.45

1.6

1.4

u/l

13.5

12.9

0.40

167

714

(3036489) Thrombin time

527

3308

1.62

23.44

2.7

2.1

22.1

21.5

0.81

462

2905

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

160

674

2.39

23.31

1.6

1.2

mmol/l

2.3

2.1

0.97

152

635

(3044889) 12 lead EKG panel

7037

64668

1.22

23.14

5.1

3.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

128

488

2.64

23.01

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

128

488

2.64

23.01

1.8

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

128

488

2.64

23.01

1.8

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

128

488

2.64

23.01

1.8

2.0

—

(3003181) Sodium [Moles/volume] in Urine

307

1668

1.86

22.87

1.5

1.3

mmol/l

64.0

63.0

0.15

245

1321

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

412

2443

1.71

22.83

3.3

2.5

211.6

195.7

2.65

379

2325

(3017732) Neutrophils [#/volume] in Blood

887

6265

1.45

22.81

3.4

3.0

e9/l

4.4

4.2

2.05

669

4751

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

269

3.25

22.79

1.6

2.0

u/l

18.5

40.5

1.40

247

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

368

2.90

22.77

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

368

2.90

22.77

2.0

2.2

—

(3042733) HLA Ab [Presence] in Serum

270

3.24

22.66

4.3

5.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

416

2479

1.70

22.63

3.8

3.0

mg/l

1.7

1.6

1.95

368

2248

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1169

8684

1.38

22.57

2.9

2.5

u/l

35.8

43.2

0.67

993

7417

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

125

477

2.64

22.44

18.3

18.1

nmol/l

7240.2

1432.0

0.50

119

461

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

278

1476

1.90

22.25

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

104

363

2.88

22.14

5.8

6.4

mmol/l

25.6

24.9

0.84

329

(3010375) cycloSPORINE [Mass/volume] in Blood

111

402

2.78

22.06

35.5

25.4

ug/l

125.4

111.0

1.37

327

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

233

1170

2.01

21.95

1.1

g/l

1.6

1.5

0.87

216

1048

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

101

349

2.91

21.90

1.2

1.1

ng/l

344.6

451.9

0.13

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

371

2.85

21.86

2.0

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

3433

29515

1.23

21.53

3.7

3.2

mmol/l

7.3

7.6

4.44

2867

24541

(3026250) Tacrolimus [Mass/volume] in Blood

103

369

2.81

20.92

39.8

34.5

ug/l

7.6

7.3

0.57

334

(3016879) Cocaine [Presence] in Urine

364

2138

1.72

20.90

4.0

2.1

—

(3011288) Drugs identified in Urine by Screen method

277

1503

1.86

20.76

5.2

3.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4418

39082

1.21

20.57

2.2

2.0

pmol/l

94.1

94.3

0.11

2378

20692

(3023410) Appearance of Cerebral spinal fluid

174

802

2.19

20.57

1.8

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

356

2088

1.73

20.55

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

327

1876

1.76

20.41

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

213

1067

2.01

20.23

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

369

2204

1.70

19.94

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

124

503

2.48

19.69

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

117

465

2.53

19.40

12.7

12.3

nmol/l

817.5

850.1

0.28

111

445

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

295

1672

1.78

19.21

1.3

1.2

u/ml

41.7

40.7

0.04

170

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

3.64

19.16

1.4

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

341

2025

1.70

18.85

3.3

3.1

nmol/l

0.8

0.03

261

1523

(3037756) Immunofixation for Serum or Plasma

357

2152

1.68

18.66

1.4

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

131

3.98

18.53

3.1

2.8

mg/l

51.5

61.9

—

(3000764) Benzodiazepines [Presence] in Urine

375

2294

1.66

18.53

4.0

2.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

201

1019

1.99

18.50

1.3

u/ml

69.5

53.2

0.42

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7257

67535

1.19

18.45

4.4

3.8

pmol/l

15.0

14.9

2.80

6591

60988

(40768804) Tissue Pathology biopsy report

4136

36664

1.20

18.14

2.3

2.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

108

429

2.53

17.97

1.3

49.1

63.8

—

(3027008) Opiates [Presence] in Urine

375

2313

1.64

17.95

4.0

2.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

109

4.23

17.79

3.1

umol/l

38.9

39.6

0.07

(3025941) Bacteria identified in Stool by Culture

700

4956

1.44

17.72

1.3

—

(3024932) HLA-DR beta [Type]

258

3.00

17.72

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9791

93940

1.25

17.65

29.1

17.7

mmol/l

139.5

139.7

9.13

9609

91532

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

874

2.04

17.56

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

256

1430

1.81

17.54

1.1

—

(3028300) Cannabinoids [Presence] in Urine

374

2319

1.63

17.54

4.1

2.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

6.32

17.52

1.2

1.1

u/l

1.9

4.5

0.60

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

370

2293

1.63

17.39

1.5

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

147

681

2.17

17.24

1.2

u/ml

91.4

69.0

0.39

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

147

685

2.16

17.00

1.2

u/ml

52.0

35.0

0.36

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

338

2.68

16.80

1.6

1.5

iu/ml

1365683.3

1433142.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

294

2.80

16.72

3.9

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

294

2.80

16.72

3.9

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

2.96

16.69

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

133

600

2.23

16.67

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

119

3.96

16.67

6.3

5.7

ug/min

42.7

45.1

0.09

(3019150) Specific gravity of Urine by Refractometry

2329

19662

1.23

16.63

5.1

4.2

kg/l

1.0

0.10

357

2974

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1293

10186

1.30

16.59

2.2

1.8

1.5

1.87

1111

8839

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

125

551

2.28

16.56

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9801

94191

1.24

16.51

29.2

17.9

mmol/l

4.0

7.03

9611

91617

(3017354) Segmented neutrophils/100 leukocytes in Blood

191

991

1.94

16.50

3.1

3.4

62.4

58.5

1.55

138

622

(3024471) HLA-A [Type]

264

2.89

16.43

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

125

553

2.27

16.42

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

192

1002

1.93

16.31

1.2

u/l

52.6

65.0

2.08

146

658

(40761535) Cells panel - Urine sediment

1038

7950

1.34

16.28

4.3

3.5

—

(3038026) Centromere Ab [Units/volume] in Serum

147

698

2.12

16.22

1.2

u/ml

49.0

63.0

—

(3002385) Erythrocyte distribution width [Ratio]

7842

73841

1.19

16.10

29.8

18.4

14.0

13.8

33.99

7713

72160

(3042517) Benzodiazepines panel - Urine

5.26

16.04

2.6

2.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

139

649

2.16

16.02

1.2

u/ml

2.0

5.8

1.08

(3027944) Amphetamines [Presence] in Urine

360

2269

1.61

15.83

3.9

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

438

2.41

15.79

2.0

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

254

1464

1.75

15.70

1.5

g/l

30.9

32.1

0.78

229

1294

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

230

1288

1.80

15.68

1.6

1.9

ug/l

19.6

23.9

0.96

221

1260

(3024891) Influenza virus A+B Ag [Presence] in Specimen

370

2354

1.59

15.65

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

277

1638

1.71

15.62

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

229

2.98

15.56

2.0

2.4

au/ml

115.8

137.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

203

1097

1.87

15.53

1.7

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1284

10192

1.29

15.51

3.3

4.0

ug/l

15.3

24.5

0.71

1021

8374

(3021960) Folate [Moles/volume] in Serum or Plasma

2592

22299

1.21

15.12

1.7

1.6

nmol/l

19.6

20.0

0.60

2243

19085

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1836

15251

1.24

15.11

3.6

3.0

e6/l

2.5

2.1

0.61

1071

8425

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.13

15.05

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

525

3636

1.46

14.95

2.2

g/l

10.4

10.3

0.30

426

3034

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

150

741

2.04

14.94

1.6

1.8

mg/l

4.0

4.4

0.60

141

700

(3044242) Glucose [Moles/volume] in Arterial blood

112

493

2.28

14.93

2.4

1.9

—

(3046861) Legionella sp Ag [Presence] in Urine

5.92

14.76

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.40

14.68

1.1

—

(3012516) Albumin [Mass/volume] in Urine

3209

28224

1.19

14.59

3.6

3.2

mg/l

643.5

416.7

1.41

2125

18106

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2122

17957

1.22

14.58

1.3

1.2

u/ml

1.8

0.02

535

4808

(3011397) Hemoglobin [Presence] in Urine by Test strip

2454

21080

1.21

14.45

4.4

3.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

239

2.86

14.45

2.1

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1946

16341

1.23

14.40

3.3

2.8

e6/l

1.1

1.3

0.54

1181

9446

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

553

3906

1.44

14.20

2.2

g/l

7.4

0.18

394

2869

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

123

576

2.15

14.13

1.2

u/l

100.6

94.2

0.37

110

488

(3045142) Bone marrow Pathology biopsy report

194

1066

1.83

14.12

1.5

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

552

3903

1.43

14.10

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

277

1686

1.66

14.06

3.6

3.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

249

2.78

13.97

2.5

3.0

mg/l

6.5

7.8

0.98

199

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

101

438

2.32

13.97

2.2

2.4

99.4

94.8

0.64

416

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

110

495

2.23

13.95

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

550

3896

1.43

13.91

2.2

g/l

3.7

3.8

0.75

385

2752

(40765096) Chromosome analysis panel by Banding

268

2.70

13.75

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

319

2022

1.59

13.75

3.7

3.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

314

2.56

13.75

3.3

2.8

umol/l

30.6

28.4

0.43

233

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

372

2445

1.54

13.68

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

3636

1.44

13.60

2.2

g/l

3.1

0.26

391

2815

(3012441) Differential panel - Pleural fluid

199

1118

1.79

13.49

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

359

2.43

13.47

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

272

2.66

13.37

1.5

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

200

1130

1.78

13.31

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

404

2720

1.50

13.29

1.4

ug/g

254.6

269.0

0.74

239

1621

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

202

1146

1.78

13.26

1.1

—

(40768446) Kidney Pathology biopsy report

333

2.47

13.15

1.8

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

968

7566

1.30

13.08

3.3

2.6

ml/min/173m2

61.0

64.3

1.86

429

3050

(3017569) Oxygen content in Arterial blood

105

479

2.20

12.92

2.5

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

232

2.77

12.89

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3347

29797

1.17

12.81

4.4

4.0

mg/mmol

10.8

9.5

0.84

2198

19023

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

153

3.21

12.80

1.1

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

117

560

2.10

12.75

1.2

u/l

25.9

23.7

0.22

105

459

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

176

970

1.83

12.74

2.9

3.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

2.74

12.43

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

227

2.74

12.27

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

233

2.71

12.23

1.1

—

(21494755) Public health laboratory ask at order entry panel

542

7378

0.72

12.10

1.3

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

179

1016

1.77

11.78

4.3

3.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

387

2649

1.48

11.77

2.3

2.2

g/l

0.0

0.00

344

2419

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

466

2.16

11.71

2.8

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

140

738

1.91

11.68

1.2

1.3

titre

—

(3037121) Protein [Mass/volume] in Urine

462

3276

1.43

11.67

3.4

3.0

g/l

0.3

0.07

216

1417

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

163

903

1.82

11.64

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

194

1135

1.72

11.50

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

1220

9983

1.25

11.32

2.2

2.3

ug/g

171.9

140.9

1.37

957

7903

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

274

2.49

11.15

1.1

—

(40768443) Skin Pathology biopsy report

560

4136

1.37

11.15

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

389

2696

1.46

11.12

2.3

2.2

g/l

0.0

1.04

344

2428

(40759836) Histone Ab [Presence] in Serum by Immunoblot

117

591

1.99

11.08

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

117

591

1.99

11.08

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

117

592

1.99

11.03

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

267

1714

1.57

10.99

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

412

2896

1.44

10.94

2.2

g/l

0.0

0.48

367

2620

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

2.68

10.89

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

597

1.97

10.78

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

597

1.97

10.78

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

597

1.97

10.78

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

149

3.03

10.72

1.2

1.1

pmol/l

2.7

4.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

418

2.16

10.68

5.7

5.0

mg/l

7464.0

645.1

1.16

288

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

452

2.11

10.60

4.0

3.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

456

3285

1.40

10.56

2.3

g/l

0.8

1.0

0.29

381

2786

(3014271) Vancomycin [Susceptibility]

110

554

1.99

10.53

3.9

2.9

—

(40768441) Liver Pathology biopsy report

126

666

1.90

10.48

1.4

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

101

3.47

10.40

1.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

425

2.13

10.25

12.6

12.0

mmol/l

0.6

0.08

389

(3016135) IgD [Mass/volume] in Serum

8.67

10.22

2.8

1.2

mg/l

39.4

82.2

0.54

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

421

3009

1.41

10.21

2.2

2.1

g/l

37.5

37.4

0.08

360

2556

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

262

2.45

10.19

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

324

2.29

10.14

1.9

1.6

umol/l

1.8

2.0

1.16

305

(3017509) Phencyclidine [Presence] in Urine

4.10

10.13

3.0

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

123

3.18

10.10

1.1

u/l

27.1

19.4

0.89

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

907

1.75

10.08

1.2

1.1

95.9

96.8

0.14

147

847

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

304

2050

1.50

10.02

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

532

7048

0.74

9.95

1.7

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

168

987

1.71

9.88

1.4

mmol/l

6.9

6.4

1.49

157

898

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

207

2.62

9.86

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

157

2.87

9.81

1.7

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8526

81925

1.15

9.75

5.3

4.6

mu/l

2.0

2.2

1.81

7782

74409

(3028679) Herpes simplex virus Ab [Presence] in Serum

388

2.15

9.73

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

122

659

1.86

9.54

1.0

mg/l

303.3

285.1

1.73

114

591

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

200

1248

1.61

9.35

1.3

1.2

u/ml

4.6

4.2

0.17

548

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.35

9.31

1.7

1.6

mg/l

2.0

1.3

0.37

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

9.27

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5610

52583

1.13

9.25

3.1

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

652

5066

1.30

9.23

1.2

iu/ml

131.5

138.1

0.16

248

1853

(3019832) Treponema pallidum Ab [Presence] in Serum

633

4902

1.31

9.19

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

159

940

1.70

9.17

1.4

mosm/kgh2o

279.4

279.1

0.05

121

709

(3000093) Morphology [Interpretation] in Blood Narrative

159

940

1.70

9.17

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

675

5283

1.29

9.05

3.7

2.8

e6/l

0.2

0.3

2.15

663

5158

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

166

997

1.67

9.04

1.5

1.3

u/l

297.2

389.1

0.98

156

940

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

120

657

1.83

9.02

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

193

1207

1.61

8.96

1.2

1.1

116.3

116.7

0.06

175

1081

(44816559) Phosphatidylethanol [Mass/volume] in Blood

238

1566

1.53

8.87

1.6

1.3

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

2.7

2.2

0.13

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

5.4

3.5

0.54

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

1.3

1.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

2.8

2.3

0.13

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

5.3

2.7

0.61

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

3.7

0.9

0.63

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

1.8

3.0

0.60

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

4.3

1.9

0.55

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.32

8.85

1.7

1.5

mg/l

1.5

1.0

0.20

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

506

1.94

8.82

1.1

nmol/l

2.2

10.2

1.42

106

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

363

2597

1.41

8.81

1.4

—

(3017704) Immunofixation for Urine

104

548

1.91

8.81

1.2

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

202

1283

1.58

8.80

1.3

1.2

u/ml

2.7

3.9

0.76

413

(3028308) Erythrocytes [#/volume] in Pleural fluid

186

1159

1.61

8.78

1.5

e6/l

81003.6

56376.0

0.29

111

690

(4306422)

196

1237

1.59

8.78

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.55

8.65

1.3

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

202

1290

1.58

8.61

1.5

e6/l

1782.8

2287.3

0.75

148

934

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

189

1190

1.60

8.56

1.5

1.4

—

(3016038) Potassium [Moles/volume] in Urine

113

619

1.83

8.50

1.3

1.2

mmol/l

31.1

35.5

1.45

524

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

134

775

1.74

8.41

1.4

1.3

u/l

12.7

13.6

0.25

125

706

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

334

4631

0.71

8.40

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

116

3.02

8.40

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

189

2.55

8.36

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

196

1254

1.57

8.31

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8810

90892

0.88

8.30

5.2

5.0

mmol/l

2.6

2.7

8.73

8050

83345

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

117

3.00

8.28

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

505

1.91

8.21

4.1

11.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

200

1292

1.56

8.14

2.8

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

184

1166

1.59

8.13

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

184

1166

1.59

8.13

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

285

1983

1.45

8.10

1.2

1.3

miu/ml

208.5

213.3

0.06

859

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

9.10

8.08

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.17

8.05

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

1169

1.58

8.05

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

183

1164

1.58

7.97

1.5

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

298

2099

1.43

7.94

1.4

u/l

11.8

10.1

1.02

245

1698

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

408

1.99

7.87

1.5

1.4

69.0

65.1

0.45

332

(3035947) Staphylolysin Ab [Units/volume] in Serum

457

1.93

7.84

1.2

1.1

iu/ml

3.0

3.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

109

607

1.80

7.82

1.6

1.5

u/l

6.5

5.6

0.22

281

(3001893) Eosinophils/100 leukocytes in Pleural fluid

342

2.08

7.79

1.6

1.4

2.5

2.6

0.04

288

(3024522) Salmonella sp identified in Specimen by Organism specific culture

183

1172

1.57

7.75

1.5

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

197

2.44

7.70

1.5

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

222

1493

1.50

7.53

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

542

1.83

7.52

1.8

1.5

u/l

5.4

6.3

1.17

461

(3027923) C peptide [Moles/volume] in Serum or Plasma

485

1.88

7.52

1.2

1.3

nmol/l

1.1

1.2

0.35

367

(3016750) Collection duration of Urine

102

565

1.81

7.46

2.9

2.1

min

497.2

497.0

0.01

407

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

348

2.05

7.46

2.5

2.0

167.7

155.5

0.48

324

(3026389) Candida sp identified in Specimen by Organism specific culture

189

1232

1.54

7.43

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

317

2287

1.40

7.40

1.7

1.6

e6/l

11624.1

15119.8

1.11

241

1645

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

123

724

1.71

7.31

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

238

1639

1.46

7.19

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

144

2.64

7.19

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

158

997

1.59

7.17

1.6

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.54

7.12

5.0

10.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

111

641

1.74

7.08

1.7

2.0

nmol/l

17.2

17.5

0.12

104

602

(3004451) EKG impression Narrative

510

1.83

7.06

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

277

2.14

6.96

1.4

1.2

24.9

25.0

—

(3008037) Lactate [Moles/volume] in Venous blood

309

2245

1.39

6.95

3.9

3.4

mmol/l

1.8

1.7

0.89

301

2190

(3022145) Colonoscopy Study observation

1200

10281

1.19

6.93

1.3

—

(3044927) Protein electrophoresis panel - Urine

160

1022

1.57

6.91

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1495

13045

1.17

6.90

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

344

2547

1.36

6.88

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

342

2530

1.36

6.88

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.42

6.76

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8640

88946

0.89

6.72

4.7

4.5

mmol/l

4.5

4.6

9.94

7968

81986

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

309

2.04

6.65

1.1

—

(4268621)

138

860

1.61

6.63

2.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

343

2557

1.35

6.59

1.3

1.2

—

(3008898) HLA-B27 [Presence]

345

2581

1.35

6.48

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

960

1.57

6.46

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

6.40

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1881

21015

0.88

6.40

2.8

3.1

ug/l

0.8

0.04

1247

14150

(3016244) Insulin [Units/volume] in Serum or Plasma

412

1.87

6.35

2.8

3.4

mu/l

28.3

26.6

0.12

386

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

324

2410

1.35

6.33

2.9

2.3

ug/min

119.2

105.3

0.21

197

1443

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

267

1926

1.40

6.31

1.7

iu/l

4.3

4.5

0.12

670

(36660697) Celiac disease serology panel - Serum

771

6401

1.22

6.26

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

452

1.82

6.17

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

245

2.13

6.13

7.6

7.5

—

(3038515) Glucose [Moles/volume] in Venous blood

289

2124

1.37

6.11

4.1

3.5

mmol/l

7.9

7.6

0.60

283

2076

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

632

5154

1.24

6.10

2.6

2.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

314

1.98

6.03

1.2

ug/l

103.1

387.0

1.11

172

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8580

88219

0.90

6.03

4.7

4.4

mmol/l

1.4

29.52

7846

80835

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

273

1994

1.38

6.00

3.1

3.4

u/ml

261.1

661.9

1.28

242

1824

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

215

2.19

5.97

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

215

2.19

5.97

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

215

2.19

5.97

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

215

2.19

5.97

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

249

2.09

5.90

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

173

1168

1.49

5.86

1.5

1.6

54.0

60.6

1.19

103

746

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

128

812

1.58

5.77

1.9

2.1

u/field

2.1

1.8

0.24

312

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

173

1178

1.48

5.64

1.1

au/ml

12.8

11.8

0.04

(21494890) Protein electrophoresis panel - 24 hour Urine

153

1016

1.51

5.64

1.7

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

122

770

1.59

5.63

1.5

1.3

—

(3004775) Volume in Urine collected for unspecified duration

127

811

1.57

5.58

2.9

2.2

652.8

641.0

0.13

528

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

255

2.04

5.56

1.8

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

178

2.25

5.46

1.1

—

(3045716) Anion gap in Serum or Plasma

441

1.77

5.45

3.6

2.2

mmol/l

8.3

9.2

1.25

343

(3035880) pH of Pleural fluid

591

1.66

5.44

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

134

876

1.54

5.33

1.6

1.5

31.5

27.9

0.55

541

(3013293) Extractable nuclear Ab [Presence] in Serum

113

2.57

5.28

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

2.41

5.27

1.2

ng/l

123.7

718.9

0.52

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2719

29408

0.90

5.18

4.0

4.4

21.4

22.1

1.33

1288

14489

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.13

5.18

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

304

1.91

5.17

1.5

1.4

21.9

20.5

0.13

274

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

13.34

5.07

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

349

1.84

5.06

1.1

miu/ml

1508.4

1540.6

0.09

349

(40758047) Lysozyme [Mass/volume] in Pleural fluid

110

2.55

5.03

1.0

1.2

mg/l

11.9

9.8

0.32

101

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

381

1.79

4.94

1.5

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.03

4.93

2.3

2.0

umol/l

1.2

1.4

1.71

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

218

1592

1.38

4.88

1.3

u/l

39.9

37.7

0.08

188

1365

(44813793)

541

1.65

4.84

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

201

2.09

4.84

1.3

1.1

—

(21494434) Karyotype in Bone marrow

125

824

1.52

4.83

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

387

1.76

4.71

1.1

u/ml

20.6

21.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

177

2.15

4.69

1.5

6.1

10.2

0.98

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

124

822

1.51

4.68

1.3

nmol/l

1.5

1.4

0.43

107

737

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

516

1.65

4.66

1.8

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

588

1.60

4.59

1.4

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

14.01

4.57

5.4

3.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

376

1.76

4.57

2.4

2.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

8.19

4.55

1.1

mg/l

2.3

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

4.54

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.55

4.53

1.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

291

1.86

4.48

2.2

2.4

nmol/l

158.2

150.8

0.18

249

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

130

2.31

4.41

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

124

2.34

4.39

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

182

1316

1.39

4.38

1.1

iu/ml

4.5

8065.9

0.55

296

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.20

4.32

1.4

1.2

u/field

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

153

1077

1.43

4.30

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

113

2.39

4.29

2.2

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

107

2.43

4.28

2.2

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

107

2.43

4.28

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

198

2.02

4.26

1.3

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.87

4.25

1.0

1.1

u/field

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

212

1.98

4.24

7.0

7.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

268

1.87

4.24

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

515

1.62

4.22

2.1

1.8

u/field

1.0

3.0

3.37

358

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

425

3471

1.23

4.16

3.1

3.4

u/ml

444.4

2112.4

1.28

354

2981

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

200

2.00

4.15

1.6

1.5

ug/l

0.4

0.06

122

(3011985) Renin [Units/volume] in Plasma

168

1211

1.39

4.14

1.6

1.4

mu/l

83.3

60.2

0.43

143

1077

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.35

4.08

1.1

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.08

4.07

1.1

1.2

—

(3019174) dRVVT (LA screen)

2.71

4.07

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

489

1.62

4.07

1.1

ratio

1.1

0.12

162

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

189

2.01

4.01

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

297

3746

0.79

4.01

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

143

2.17

3.97

1.4

1.5

—

(40761511) CBC panel - Blood by Automated count

9542

93645

1.10

3.95

23.9

14.4

—

(3032057) Clostridioides difficile [Presence] in Stool

232

1.90

3.94

2.1

1.8

—

(3003694) ABO and Rh group [Type] in Blood

2526

23496

1.10

3.93

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

268

2090

1.29

3.91

4.6

3.6

mg/l

26.2

28.6

0.55

173

1360

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

2.22

3.91

5.8

5.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

282

2214

1.28

3.90

1.9

1.7

mu/l

334.7

298.0

0.82

261

2019

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

464

3856

1.21

3.85

3.3

3.7

u/ml

57.8

61.1

0.11

445

3706

(1761868) Lipid panel - Serum or Plasma

2880

30702

0.92

3.85

3.2

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

427

1.64

3.84

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9790

96238

1.10

3.80

28.7

17.8

umol/l

83.6

80.9

7.80

9781

96199

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.80

1.3

1.2

mmol/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

483

1.60

3.79

1.1

u/l

92.4

89.4

0.10

381

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.47

3.78

1.8

2.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

179

1326

1.36

3.77

3.1

3.7

u/ml

26.2

31.9

0.67

168

1286

(3023323) Follitropin [Units/volume] in Serum or Plasma

364

2965

1.23

3.69

1.4

1.3

iu/l

30.8

31.0

0.02

301

2558

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

386

1.66

3.68

2.5

2.2

umol/l

57.6

54.5

0.32

318

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

109

2.30

3.67

1.1

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.86

3.62

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.25

3.62

1.3

1.2

u/field

0.7

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

782

1.45

3.55

1.6

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

2.30

3.42

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

482

1.56

3.37

1.1

u/l

31.7

27.4

0.35

363

(3035320) C reactive protein [Mass/volume] in Body fluid

660

1.47

3.35

2.8

2.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

580

1.50

3.32

1.6

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

209

1621

1.29

3.25

1.4

pmol/l

185.4

169.5

0.11

203

1584

(3029075) Extractable nuclear Ab panel - Serum

234

1.80

3.23

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

4.74

3.23

4.3

8.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

328

2685

1.23

3.23

1.8

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.38

3.22

1.8

1.6

umol/l

50.8

42.7

0.95

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

675

1.46

3.20

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

1199

1.34

3.19

2.3

2.0

mg/l

26.8

25.1

0.13

306

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.27

3.18

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

474

1.54

3.16

1.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8684

85109

1.08

3.16

22.4

14.3

ml/min/173m2

78.2

78.5

0.48

7632

70671

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

137

2.05

3.15

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

137

2.05

3.15

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

137

2.05

3.15

1.4

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

200

1.85

3.14

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

144

2.02

3.14

1.5

1.3

19.2

24.7

0.43

110

(3020876) Protein [Mass/time] in 24 hour Urine

119

853

1.40

3.13

1.9

g/24h

0.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

358

1.62

3.11

1.0

1.1

u/ml

10.3

5.2

0.36

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.28

3.09

2.0

1.9

mmol/l

1.0

0.03

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

225

1775

1.27

3.08

2.2

1.8

nmol/l

1.0

0.8

2.96

189

1474

(3044941) Cell count panel - Synovial fluid

188

1452

1.30

3.04

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

460

3914

1.18

3.03

1.3

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.84

3.02

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

448

1.54

3.01

1.5

7.3

3.3

1.25

107

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

151

1133

1.34

3.01

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

218

1.79

2.99

1.3

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.00

2.98

5.2

3.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.63

2.96

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

219

1.78

2.95

1.4

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

474

1.52

2.95

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

120

872

1.38

2.94

1.1

u/ml

3.1

3.7

0.22

340

(3003338) MCHC [Mass/volume]

7403

75791

0.94

2.91

32.0

19.5

g/l

331.3

332.3

15.93

7324

75101

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.32

2.90

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8374

85366

0.93

2.87

4.3

4.0

mmol/l

1.4

1.3

16.77

7641

77603

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.59

2.87

1.3

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

478

1.51

2.85

1.1

iu/ml

9.9

10.5

0.06

120

(3002619) Bacteria identified in Specimen by Culture

178

1.86

2.85

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

252

1.71

2.83

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

463

1.51

2.83

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

463

1.51

2.83

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

660

1.43

2.82

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

260

1.69

2.81

1.4

22.5

0.00

215

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

139

1042

1.34

2.81

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

165

1.88

2.79

1.1

1.2

78.7

74.8

0.18

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

209

1658

1.27

2.78

2.2

2.1

u/l

3683.3

4117.0

0.08

631

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

239

1.72

2.76

1.2

1.1

76.3

87.8

0.79

122

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

293

1.64

2.73

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

549

1.46

2.72

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

163

1257

1.30

2.71

1.3

nmol/l

0.6

2.7

1.00

151

1213

(3034426) Prothrombin time (PT)

309

1.62

2.71

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

167

1.86

2.70

7.6

7.4

—

(3036180) Methadone [Presence] in Urine

6.00

2.69

5.2

2.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.50

2.69

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

105

2.10

2.68

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.12

2.64

2.5

2.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.21

2.63

1.0

1.2

umol/24h

1.7

0.06

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

706

6273

1.13

2.63

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.55

2.61

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

236

1.70

2.60

1.2

77.8

86.9

0.42

123

(3050794) Legionella sp Ab [Presence] in Serum

2.25

2.60

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

121

901

1.35

2.59

1.5

1.3

e6/l

100851.3

144488.3

0.38

608

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

100

2.10

2.58

1.0

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

300

1.60

2.51

1.4

1.2

g/l

37.5

39.4

0.32

161

(3049717) Cytology report of Urine Cyto stain

471

4086

1.16

2.50

2.5

2.8

—

(40768800) Prostate Pathology biopsy report

179

2250

0.79

2.49

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

165

1.82

2.48

1.1

1.2

90.7

78.2

0.93

(4034850)

352

2987

1.18

2.46

14.2

10.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.67

2.44

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.55

2.44

1.1

g/l

0.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

480

1.46

2.43

3.2

2.6

u/l

202.1

204.6

0.12

474

(3020961) Endomysium IgA Ab [Titer] in Serum

438

3790

1.16

2.41

1.1

titre

248.0

217.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

555

1.43

2.41

1.3

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

539

1.43

2.40

1.8

2.3

umol/l

12.8

27.9

1.11

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.00

2.40

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

124

1.94

2.39

1.1

1.3

nmol/l

4.5

317483.5

0.91

103

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

634

5637

1.13

2.36

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

2.26

2.33

1.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

677

1.38

2.33

2.0

1.9

mmol/l

7.9

6.9

1.56

462

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

123

935

1.32

2.33

1.4

1.3

—

34.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

602

1.40

2.31

1.8

2.0

umol/l

7.0

10.3

0.95

427

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

140

1.86

2.31

11.7

11.5

mmol/l

4.6

5.6

2.09

140

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

259

2152

1.21

2.31

1.1

u/ml

3.2

8.0

2.20

237

(44806071)

112

1.97

2.29

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.37

2.28

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

160

1263

1.27

2.28

1.3

nmol/l

0.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

238

1.64

2.27

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

141

1.85

2.26

1.4

1.5

—

(40768793) Breast Pathology biopsy report

208

1694

1.23

2.26

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.02

2.25

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1225

11313

1.09

2.25

4.4

4.6

32.3

32.4

0.15

913

7630

(46236302) HLA-C [Type] by High resolution typing

3.10

2.22

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.10

2.22

1.0

—

(40763590) HLA-DQ beta [Type]

3.10

2.22

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

170

1358

1.26

2.21

1.1

u/ml

1.9

1.6

0.14

540

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

150

1.80

2.19

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.13

2.18

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

188

1.70

2.16

1.3

1.6

au/ml

120.6

64.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

173

1.74

2.16

1.3

1.2

mg/l

195.6

63.9

0.29

130

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.29

2.15

1.3

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

242

1.61

2.15

1.3

1.6

g/l

14.5

13.4

0.25

192

(1761482) Bacteria [#/volume] in Urine by Culture

311

2651

1.18

2.11

5.1

4.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

299

1.54

2.09

1.2

1.5

pmol/l

18.1

15.3

0.47

246

(3009015) Lactate [Moles/volume] in Synovial fluid

102

1.96

2.09

1.5

1.2

mmol/l

5.0

6.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

142

1119

1.27

2.09

1.3

nmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.50

2.05

1.9

4.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.32

2.04

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

111

1.89

2.00

2.4

2.6

u/field

0.3

0.5

0.23

111

(3022621) pH of Urine by Test strip

673

6076

1.11

1.98

3.2

3.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

145

1810

0.80

1.97

1.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

604

1.36

1.96

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

186

1.67

1.96

1.0

1.1

umol/24h

0.6

0.7

0.26

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

119

1.85

1.96

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.33

1.96

9.7

8.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

436

1.42

1.95

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.35

1.94

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

144

1149

1.26

1.93

1.2

1.3

pmol/l

412.6

305.5

0.49

102

870

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

210

1.62

1.93

3.0

2.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

210

1.62

1.93

1.1

1.2

pmol/l

399.7

263.2

0.75

150

(3043410) Blood group antigens tested for on Red Blood Cells

266

1.54

1.91

1.6

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3558

36900

0.95

1.90

4.6

5.0

ug/l

3.2

3.6

0.52

3092

32921

(3000012) Reticulocyte production index

582

1.36

1.90

1.7

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

2.31

1.87

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

213

1.60

1.84

1.3

g/l

26.4

25.5

0.11

161

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8520

83943

1.05

1.82

7.0

6.0

mmol/mol

41.5

40.2

19.98

7860

77265

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

101

1.88

1.80

1.1

1.2

ug/l

65.2

116.3

—

(40760410) HLA-B [Type] by High resolution

2.76

1.79

1.0

—

(40760409) HLA-A [Type] by High resolution

2.76

1.79

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

153

1.70

1.79

1.4

1.3

mmol/l

0.6

1.5

1.15

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9733

96271

1.06

1.78

15.8

10.5

u/l

27.8

26.6

3.36

9486

92591

(3002256) Pathology report gross observation

1294

12104

1.08

1.78

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

8277

81523

1.05

1.74

25.9

16.3

38.9

39.6

7.77

5401

56551

(4281824)

115

908

1.27

1.72

1.2

—

(3013862) HLA-DP [Type]

2.67

1.72

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.85

1.71

1.4

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

227

1925

1.18

1.71

2.1

1.9

pmol/l

194.2

200.6

0.45

209

1807

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.29

1.70

4.5

3.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

227

1.54

1.67

1.6

1.7

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.16

1.66

6.8

4.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

196

1.58

1.64

1.0

1.1

—

(3024263) Appearance of Synovial fluid

513

1.35

1.61

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

205

1.56

1.61

1.3

—

(3045424) Erythrocytes [Presence] in Urine

181

1514

1.20

1.61

1.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

148

1216

1.22

1.58

1.1

u/ml

3.6

5.1

0.55

605

(3049242) von Willebrand panel - Platelet poor plasma

3.00

1.58

1.2

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.69

1.58

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

116

930

1.25

1.56

1.4

nmol/l

0.3

0.46

690

(3014133) Dog dander IgE Ab [Units/volume] in Serum

118

948

1.25

1.56

1.1

u/ml

4.0

3.2

0.21

360

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

240

2783

0.86

1.55

1.7

1.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.85

1.55

1.1

1.3

pmol/l

15.7

19.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.11

1.54

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

475

1.35

1.53

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.33

1.52

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.33

1.52

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.33

1.52

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.33

1.52

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.33

1.52

1.8

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.33

1.52

3.4

1.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.33

1.52

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

241

1.50

1.51

1.5

2.0

mg/l

8.0

9.5

0.70

195

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.86

1.50

4.0

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.86

1.50

4.3

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.95

1.48

2.0

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

1.48

1.1

—

(3047189) Immunofixation for 24 hour Urine

471

1.34

1.45

1.7

1.6

—

(3000330) Specific gravity of Urine by Test strip

534

4856

1.10

1.45

4.4

3.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.13

1.44

1.0

1.4

mmol/24h

1.6

2.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.73

1.43

1.3

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.31

1.42

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

311

1.42

1.8

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

237

1.48

1.41

1.4

1.3

nmol/l

141.0

133.1

0.08

185

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.25

1.40

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

126

1.67

1.39

2.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

126

1.67

1.39

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

191

1.52

1.34

1.1

1.0

—

(3045414) Leukocytes [Presence] in Urine

444

4023

1.11

1.32

2.1

1.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

136

1.62

1.32

1.4

1.3

u/l

205.9

301.0

0.14

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

136

1.62

1.32

1.6

1.3

59.7

54.1

0.23

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.09

1.30

1.8

2.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.78

1.28

2.0

2.2

—

(3048879) Bone marrow aspiration report

293

1.40

1.27

2.2

1.8

—

(3022475) Manganese [Moles/volume] in Blood

2.00

1.27

1.3

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.29

1.26

1.0

1.1

—

26.9

—

(3025130) Human papilloma virus identified in Specimen

101

823

1.23

1.24

1.6

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

123

1.63

1.23

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.00

1.23

1.6

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

220

1.46

1.22

2.1

2.4

mmol/l

8.1

7.9

0.09

133

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

663

1.25

1.22

1.3

1.2

mmol/l

12.1

11.8

0.09

199

(3006442) Creatine [Moles/volume] in Serum or Plasma

646

1.26

1.20

1.8

1.6

umol/l

75.0

70.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

132

1109

1.19

1.1

u/ml

3.7

1.9

0.40

258

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.75

1.18

1.0

1.1

iu/ml

6.7

11.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

170

0.53

1.17

2.6

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

170

0.53

1.17

5.1

5.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.05

1.15

4.4

9.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

174

1.50

1.14

2.1

1.5

ng/l

110.8

143.6

0.65

174

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

118

987

1.20

1.13

1.4

1.3

u/l

31.1

29.5

0.17

102

798

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

283

1.38

1.13

1.3

1.2

g/l

0.3

2.37

233

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.33

1.12

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.33

1.12

1.1

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

138

1175

1.18

1.10

1.1

u/ml

1.9

1.1

0.23

492

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

526

0.74

1.09

1.2

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.19

1.08

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.63

1.03

1.4

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

114

1.58

1.02

1.6

1.7

—

(3006462) Nitrate [Presence] in Urine

438

1.28

1.01

3.2

3.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.77

1.00

2.9

2.6

pmol/l

37.5

65.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.77

1.00

1.7

1.1

—

(40758358) Immune stain study

2.00

1.00

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

390

0.72

0.98

1.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

612

1.23

0.96

1.9

2.0

ug/l

2.4

0.01

505

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.69

0.95

1.8

22.4

17.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

259

1.35

0.94

1.8

1.5

ug/l

8.9

9.2

0.22

259

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.65

0.94

2.1

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.65

0.94

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.89

0.94

5.3

8.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

150

1.47

0.92

3.7

2.8

ng/l

94.8

150.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

431

0.74

0.92

1.3

mmol/l

6.0

0.04

409

(3002523) Influenza virus A Ag [Presence] in Specimen

137

1187

1.16

0.92

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

137

1188

1.15

0.91

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

138

1584

0.87

0.89

1.5

—

(3014891) Appearance of Pleural fluid

160

1.44

0.88

1.7

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

271

1.33

0.88

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

648

1.20

0.86

1.2

1.3

titre

1526.0

307.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

649

0.80

0.86

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

361

1.28

0.85

1.0

1.1

94.0

96.2

0.21

280

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1231

11803

1.05

0.84

11.4

7.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

336

1.28

0.82

1.6

2.1

e6/l

1077.7

3379.2

0.47

231

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

383

1.25

0.79

1.4

1.6

nmol/l

3.4

5.4

0.59

316

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

303

1.29

0.79

1.6

1.9

e6/l

31357.3

15707.0

0.36

167

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.82

0.79

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

628

1.20

0.79

1.9

ug/l

6.1

3.6

0.69

549

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

739

1.18

0.78

1.6

u/ml

25.0

26.4

0.09

161

(4212803)

1.53

0.78

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

286

1.29

0.78

1.9

1.3

umol/l

3.3

3.8

0.48

265

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.56

0.78

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

345

3190

1.08

0.77

1.6

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

1.76

0.76

1.2

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

288

2644

1.09

0.76

1.9

1.8

nmol/l

40.1

40.9

0.26

277

2552

(3017446) Testosterone [Moles/volume] in Serum or Plasma

776

7380

1.06

0.75

2.5

2.2

nmol/l

12.1

12.6

1.00

671

6499

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

429

4007

1.07

0.74

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

267

0.71

0.74

1.7

1.5

mmol/l

8.5

8.4

0.06

154

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.08

0.74

1.2

1.0

—

(40758292) HTLV I+II Ab panel - Serum

141

1.42

0.74

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

108

1.48

0.73

15.4

9.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1088

0.86

0.73

1.2

mmol/l

7.4

7.5

0.12

792

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.00

0.72

1.4

1.2

nmol/l

205.9

452.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.80

0.72

1.7

1.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.92

0.70

6.6

4.5

mg/l

7.4

3.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

718

0.83

0.70

1.3

pmol/l

51.5

107.0

0.74

232

(3035933) Granulocytes/100 leukocytes in Blood

212

1.32

0.70

4.3

1.5

—

(4211845)

482

1.20

0.68

3.2

3.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.67

0.68

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.59

0.65

2.6

5.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.67

0.61

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

113

1.42

0.61

1.4

1.9

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

12459.9

—

(3015183) Erythrocyte sedimentation rate

371

1.21

0.60

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.53

0.59

1.3

mmol/l

22.9

21.9

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.51

0.58

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

246

1.26

0.58

3.5

5.8

67.8

70.4

0.20

194

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

193

1.30

0.57

1.1

u/ml

12.5

5.7

—

(4146454)

114

1018

1.12

0.57

2.5

2.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.51

0.56

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.45

0.56

1.1

1.5

umol/24h

259.8

323.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

320

1.22

0.55

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.58

0.54

1.2

1.1

nmol/l

293.5

253.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.46

0.54

1.2

1.1

u/l

5.7

13.2

1.34

(3021162) Amylase [Enzymatic activity/volume] in Specimen

169

1.30

0.53

2.0

2.8

u/l

637.6

2913.8

1.22

157

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

108

1.39

0.53

1.1

1.0

—

(1002224) Polysomnography panel

366

3454

1.06

0.53

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

382

0.81

0.52

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.52

0.52

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

629

1.15

0.51

1.0

ng/l

292.8

320.2

0.59

429

(3000034) Microalbumin [Mass/volume] in Urine

101

903

1.12

0.51

3.8

3.0

mg/l

96.6

54.3

0.36

658

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

170

1.29

0.51

1.9

ug/l

2.0

2.4

0.41

(3019897) Erythrocyte distribution width [Ratio] by Automated count

107

960

1.12

0.51

4.2

2.9

13.4

13.2

1.49

107

946

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

251

1.24

0.50

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.47

0.50

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.41

0.50

2.1

1.9

64.0

61.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

407

1.18

0.50

1.0

1.1

u/ml

0.6

1.6

0.67

122

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

118

1067

1.11

0.49

1.1

u/ml

3.2

3.5

0.07

465

(37021550) Renin [Units/volume] in Plasma --upright

198

1.26

0.49

1.1

1.3

mu/l

86.2

60.7

0.31

144

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

732

0.87

0.48

1.3

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

606

1.14

0.47

1.2

—

(3044007) Cell count panel - Peritoneal fluid

273

1.21

0.45

1.7

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

553

5760

0.96

0.45

1.2

—

(4094501)

232

2474

0.94

0.44

1.1

—

(3020650) Glucose [Presence] in Urine

220

1.23

0.43

1.8

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

202

1.24

0.43

1.3

1.2

mmol/l

1.2

1.6

1.41

121

(3007916) DNA double strand Ab [Titer] in Serum

104

1.35

0.43

1.1

1.3

—

110.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

122

1.31

0.42

2.0

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

632

1.12

0.41

1.0

ng/l

758.3

722.6

0.29

418

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

794

1.11

0.41

1.0

1.1

u/ml

2.1

0.4

0.41

184

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

(3025315) Body weight

1.39

0.40

7.5

4.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

511

1.14

0.40

2.3

2.1

ug/min

207.9

152.0

0.19

124

(3014051) Protein [Presence] in Urine by Test strip

217

2039

1.07

0.40

2.4

2.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.40

0.0

1.2

—

3211.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

635

1.12

0.39

1.0

ng/l

43.5

42.9

0.05

425

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

750

1.11

0.38

4.0

5.0

u/ml

94.5

71.2

0.18

217

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

391

1.15

0.38

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

9977

100096

0.98

0.38

37.3

22.4

g/l

132.8

135.3

46.09

9841

98462

(3050129) First trimester maternal screen panel - Serum or Plasma

999

0.91

0.38

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

477

1.13

0.37

2.1

1.5

ug/l

3.2

4.0

0.36

386

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

158

0.76

0.37

2.8

2.9

—

(3010813) Leukocytes [#/volume] in Blood

9979

100102

0.98

0.36

37.0

22.3

e9/l

7.0

6.8

12.76

9755

96984

(3032868) Hemoglobin electrophoresis panel in Blood

0.65

0.35

1.8

1.5

—

(4038314)

1.43

0.35

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

9977

100075

0.98

0.35

37.0

22.2

e12/l

4.4

4.5

15.56

9754

96970

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1034

10591

0.97

0.35

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

827

0.91

0.35

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2314

23486

0.98

0.35

1.7

1.6

mmol/l

1.5

1.4

6.26

1920

19569

(3045462) Protein/Creatinine [Ratio] in Urine

1.37

0.34

5.8

3.6

g/mol

34.2

40.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

826

0.91

0.34

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

899

0.91

0.34

1.4

1.5

—

(3024731) MCV [Entitic volume]

9977

100065

0.98

0.33

36.8

22.2

91.1

91.3

3.11

9851

98428

(3035941) MCH [Entitic mass]

9977

100062

0.98

0.33

36.8

22.1

30.2

30.4

17.93

9851

98425

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.70

0.33

1.2

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

718

0.90

0.32

1.4

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

137

1.24

0.32

1.1

u/ml

56.9

61.7

0.10

130

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

316

0.85

0.31

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.35

0.31

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

829

0.92

0.30

1.3

1.4

—

(3007461) Platelets [#/volume] in Blood

9974

100010

0.98

0.30

37.0

22.3

e9/l

248.4

246.1

2.69

9783

97220

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

828

0.92

0.29

1.3

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.25

0.29

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

691

0.91

0.28

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.27

0.27

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

930

9106

1.02

0.27

1.6

—

(44806420)

299

1.14

0.27

2.0

2.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

204

0.83

0.26

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

218

2280

0.96

0.26

1.5

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

272

1.14

0.26

2.1

1.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.20

0.25

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

694

0.92

0.24

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

155

1474

1.05

0.24

1.8

1.7

—

(3006270) Folate [Moles/volume] in Blood

852

1.07

0.23

1.3

1.2

nmol/l

341.1

348.3

0.14

694

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

318

3078

1.03

0.22

2.0

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

168

0.83

0.22

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.25

0.22

1.2

1.1

mmol/l

9.1

8.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

128.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

167.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

182

1.15

0.21

4.8

4.7

u/l

48.2

60.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

325

0.89

0.21

1.1

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

0.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

202

1.14

0.20

1.2

1.3

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.18

0.19

2.7

3.3

—

0.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

222

1.13

0.19

2.0

2.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

661

0.94

0.17

1.5

—

(4133840)

246

0.89

0.16

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

139

1.15

0.16

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.13

0.15

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

213

0.89

0.15

1.4

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.81

0.13

1.5

2.4

—

(40762814) Titanium [Mass/volume] in Blood

170

1.12

0.13

2.3

2.2

ug/l

7.0

3.6

—

(3001729) Color of Synovial fluid

1.18

0.12

2.2

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

299

1.07

0.10

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

1.06

0.09

1.4

1.3

umol/l

100.8

85.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

536

1.04

0.09

5.4

6.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.11

0.09

1.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.07

0.08

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8763

87732

1.00

0.08

5.1

4.7

mmol/l

6.1

6.0

6.57

7966

79513

(3038177) Helicobacter pylori Ab [Presence] in Serum

143

1400

1.02

0.07

1.2

1.3

—

(4024509)

885

1.03

0.07

1.7

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.84

0.07

2.0

2.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.05

0.07

1.0

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

187

1.07

0.06

1.1

u/ml

0.4

6.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

305

1.05

0.06

1.5

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

445

1.03

0.05

6.6

5.7

u/ml

37.1

8026.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

384

0.96

0.05

2.8

2.5

—

(3051101) Glucose [Moles/volume] in Cord blood

191

0.94

0.04

4.6

6.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

246

2445

1.01

0.02

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

399

0.98

0.02

1.0

u/ml

3.2

0.9

0.39

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

411

1.02

0.02

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

659

6606

1.00

0.01

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

233

0.99

0.00

1.1

1.3

42.2

35.0

—

158

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

204

2042

1.00

0.00

1.5

—

(3022689) Creatine [Moles/volume] in Urine

265

1.02

0.00

1.3

1.4

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

21.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

68.7

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

5.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.92

0.00

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.4

—

(3001556) Androgen free Index in Serum or Plasma

0.89

0.00

1.8

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.99

0.00

5.1

4.8

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

15.6

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.96

0.00

9.4

4.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.02

0.00

1.4

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_FOR_EXCL – Diagnoses used for exclusion with ILD

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Diagnoses used for exclusion with ILD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints